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ABSTRACT

Solubility is a critical factor of protein-based drugs during processing and patient
administration. This study focused on two aspects of solubility: one was the poly
(ethylene) glycol (PEG) precipitation of monoclonal antibodies (mAbs) and another was
crystallins aggregation that is associated with cataracts. Protein precipitation by PEG is a
common technique for downstream processing. The effects of pH, ionic strength and the
exclude volume effect on the protein precipitation by PEG were extensively studied, but
the effects of glycosylation on protein precipitation by PEG has not been examined.
Protein aggregation is not only a problem in downstream processing, but it is also related
to some diseases. In 2015, lanosterol and 25-hydroxycholesterol were reported to
dissolve protein aggregates in cataract lenses. Researchers focused on dissolution of lens
protein aggregates, but the effects of those two sterols on the formation of aggregates
were not investigated. The objectives of this dissertation were: 1) to determine the role of
glycosylation in the precipitation of mAbs by PEG, and 2) to study the effects of
lanosterol and 25-hydroxycholesterol on a-crystallin aggregation. The glycosylated mAbs
showed higher solubility than non-glycosylated mAbs. It was found that available
solubility models cannot correlate the effect of glycosylation. Lanosterol and 25hydroxycholesterol failed to prevent a-crystallin aggregation. A concentration of 125pM
of the two sterols promoted the aggregation of a-crystallin and of the a/y complex
possible by serving as nucleation sites. The secondary and tertiary structures of acrystallin were not affected upon addition of the two sterols. The a-crystallin chaperon
activity and the capacity of binding with Cu2+were not affected either.
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1. INTRODUCTION

With the development of recombinant technology, the commercial production of
medicinal protein preparations became a reality. The preparation of a protein as a
pharmaceutical drug became an indispensable part of the pharmaceutical industry.
However, the solubility of proteins during processing and storage affected its medical and
commercial applications. Proteins are the final product of DNA translation. Proteins
serve as enzymes, carriers of cell signaling and ligand binding, and are structural
components. Each protein has distinctive structures that support their biological
functions. The protein solubility is a determining factor for their biological functions.
For example, keratin is a type of insoluble protein that is the structural material for hair
and nails[1]; crystallins require high solubility to maintain eye lens transparency.[2]
Protein aggregation is a consequence of soluble protein molecules forming insoluble
aggregate. Undesired protein aggregates lead to diseases like cataracts.
In this dissertation, protein solubility was studied from two different
perspectives. One was the poly (ethylene) glycol (PEG) precipitation of monoclonal
antibodies (mAbs) and the other was the effects of lanosterol and 25-hydoxycholesterol
on the a-crystallin aggregation processes.

1.1. PROTEIN STUCTURE
Proteins have four levels of organization that makes each protein type unique. The
primary structure of a protein refers to the amino acid sequence that forms the peptide
chain; i.e. the sequence of amino acid residues in the protein molecule, including their
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number, type and sequence. Amino acids are connected to each other by peptide bonds,
i.e. a molecule of water is removed between the a-amino group of one amino acid and the
a-carboxyl group of another amino acid. Peptide bonds have the properties of partial
double bonds, so the entire peptide unit is a rigid planar structure. The end of the
polypeptide chain containing a free amino group is called the N-terminus of the peptide
chain, and the end containing a free carboxyl group at the other end is called the Cterminus of the peptide chain. Changes in the primary structure of a protein can change
its secondary structure and its function.[3]
Secondary structure refers to the structure formed by the folding of the
polypeptide chain backbone. The most basic types of secondary structure are a-helical
and P-sheet structures; both structures are maintained by hydrogen bonds. There are also
P-turns and random coils. Each peptide bond in the helix is involved in the formation of
hydrogen bonds to maintain the stability of the spiral. P-sheet structures are also
common. In this structure, the polypeptide chain exists in a relatively stretched form, and
the arrangement of the peptide chains (or peptide segments) can be parallel or
antiparallel. The axial distance between amino acids is 0.35 nm, and adjacent peptide
chains are connected to each other by hydrogen bonds to form a layered structure.[4]
The tertiary structure of a protein is the three-dimensional shape of the entire
polypeptide chain formed by further folding and rolling of secondary structures. Amino
acids interact with one another via charge-charge, hydrophobic, disulfide, or other
interactions. The polypeptide chains of rhe protein are coiled and folded in multiple
directions in a three-dimensional space to form a tight, approximately spherical structure.
The space inside the molecule can only accommodate a few water molecules. Almost all
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polar side chains are distributed on the outer surface of the molecule to form a
hydrophilic shell, while most non-polar side chains are buried inside the molecule and do
not contact water. The interaction of side chain in protein molecules plays an important
role in stabilizing the tertiary structure of proteins.[5]
The quaternary structure refers to the structure of a protein formed by interactions
between multiple polypeptide chains. In a protein with a quaternary structure, each
peptide chain with a tertiary structure is called a subunit. The absence of a subunit makes
the protein biologically inactive. The quaternary structure involves the spatial
arrangement of subunits in the entire molecule and the relationship between subunits.[6]

1.2. PROTEIN SOLUBILITY
The solubility of a protein is affected by changes in pH, temperature, ionic
strength, the addition of cosolvents[7], and by post-translational modifications like
glycosylation. Each of these environmental factors directly affects protein solubility. The
pH and ionic strength both affect the net charge of protein. A few amino acids are weak
acids and basis; therefore, proteins normally bear a net charge. At the pH equal to the
isoelectric point (pI) of a protein, the protein molecules exist in the form of zwitterions,
and their net molecular charge is zero (that is, the positive and negative charges are
equal). At pHs below or above the pI, the protein is positive-charged or negative-charged
respectively. For a pH near the pI, protein’s solubility is at a minimum because the
electrostatic repulsive force was minimized.[8] When the force is weakened,
intermolecular collisions lead to aggregates that eventually precipitate. Therefore, when
the pH of a protein solution is at the pI, the protein solubility is the lowest and a
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precipitate is most likely to form. Many physical properties at the pI, such as viscosity,
swelling, and osmotic pressure are reduced, which is beneficial to the filtration of the
suspension.[9] The effects of ionic strength on the protein solubility depend on pH.
Briefly, at a pH near pI the addition of salt to a protein solution first increases (salting-in)
and then decreases (salting out) protein solubility. At pHs below or above pI, the addition
of salt first decreases protein solubility by screening electrostatic repulsions and then it
raises protein solubility due to 1) the interaction between weakly hydrated monovalent
anions and polar and nonpolar groups on the protein surface; 2) the interaction between
amide bond and multivalent cation.[10]
The solubility of a native protein also decreases as the temperature decreases. An
increase in temperature unfolds the protein; therefore, it induces the formation of
aggregates that eventually precipitate. High temperatures not only affect the secondary
structure of a protein, but also, in some cases, it alters the quaternary structure of a
protein oligomer, i.e. the a-crystallin that belong to the small heat shock protein form
larger oligomers at temperatures higher than 37oC.
Dehydration of a protein is the main mechanism for protein destabilization caused
by the addition of cosolvents. Protein precipitation by alcohols has a long history. The
alcohols disrupt the hydration shell of protein that leads to aggregation and precipitation.
To prevent irreversible protein aggregation, alcohol precipitation is usually conducted at
4 oC.
Non-ionic polymers include dextran and poly (ethylene) glycol (PEG) were used
to precipitate proteins. This phenomenon were explained by exclude volume theory that
was first introduced by Asakura and Oosawa.[11] The non-ionic polymer molecules were
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excluded from the volume between two protein molecules, then the volume between two
protein molecules becomes a phase of pure solvent; therefore, the particular distribution
of the polymer causes a pressure imbalance that pushes the proteins against each other,
known as the exclude volume theory. PEG precipitation has been used, for example, for
the crystallization of glycosylated and non-glycosylated variants of agglutinin, extraction
of chicken IgY from egg yolk[12], precipitation of lysozyme[13], and coupled with
chromatography to purify botulinum neurotoxin type B, among other uses.[14]
Post-translational modifications also affects protein solubility. Common post
translational modifications include: acylation, acetylation, alkylation, glycosylation
etc. [15] Glycosylation consists of the addition of various glycan groups to the
polypeptide chain.[16] Glycosylation may protect proteins from stresses that destabilize
them, such as precipitants, pH, chemicals, and heat.[17] Aggregation is a known
phenomenon observed in commercial antibodies preparations (particularly after
reconstituting a freeze-dried sample).[18] The formation of biologically inactive
aggregates decreases their efficacy. Moreover, there is evidence that protein aggregates
present in a protein drug increase immunogenicity.[19, 20] It was argued that
glycosylation increased the stability of the protein; therefore, it was expected that a nonglycosylated antibody was more susceptible to aggregation.[21]
Precipitation is an important downstream processing step. Precipitants are used to
lower protein solubility and induce protein solid-liquid or liquid-liquid phase-separation
to separate proteins from undesired impurities. Salts, organic solvents, and non-ionic
polymers (PEG and dextran) are frequently used precipitants. One of the advantages to
used PEG is that it precipitates proteins without. pH, ionic strength, and temperature are
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critical factors in PEG precipitation,[22-24]and they were extensively studied as evident
in previous related literature. Depletion and electrostatic forces control the extent of
protein precipitation by PEG. However, the role of glycosylation is unclear, creating a
gap in the literature.
In paper I, glycosylated and non-glycosylated mAbs were selected as models to
study the effect of glycosylation on protein precipitation by PEG. PEG 1450 Da and 8000
Da were used. The effects of pH and temperature were also explored. Additional studies
were performed in the presence of a Griffonia (Bandeiraea) simplicifolia Lectin II (GSLII), which binds to glycosylated proteins. The precipitation curves were fitted with a
Cohn salting-out equation analogous. The PEG precipitation efficiency coefficient, which
was extracted from the curve fitting, was compared to the available solubility models.
This study’s data showed that glycosylation enhanced the mAbs solubility in the presence
of PEG.

1.3. DISSOLUTION OF CATARACTS BY THE ADDITION OF STEROLS
Mammals’ eye lenses have onion-like layered structures. The outward facing edge
of the lens consists of a mono-layer of epithelial cells that differentiate to new fiber cells
during the development of lens over the lifetime of an individual.[25] In order to
maintain the transparency of the lens, the fiber cells lack of blood vessels and the sub
cellular structures. The lenses’ high refractive index is caused by the high concentration
of crystallins expressed in fiber cells, which require high solubility of crystallins.
Conversely, lens fiber cells lack the capacity for protein turnover and repair.[26] The
degradation of crystallins accumulate over a lifetime and thus their solubility decreases.
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The low solubility of aged crystallins results in aggregation, and they finally increase the
scattering of light and form cataracts.[27, 28]
Cataracts cause approximately 50% of blindness worldwide.[29] Cataract surgery
is readily available in the developed world, but it is less common in underdeveloped
countries. Surgery is invasive and requires relatively sophisticated equipment;
additionally, well-trained physicians are scarce in the underdeveloped world. Moreover,
surgeries are almost nonexistent in large underprivileged populations in Asia, Africa, and
the Middle East as well as in Central and South America. Curing cataracts using eye
drops is a very attractive and financially sound alternative.
Zhao et al.[30] discovered that lanosterol (a triterpenoid and a precursor of
cholesterol that accumulates in the eye lenses) can dissolve congenital cataracts in rabbits
and dogs. Their work was inspired by the observation that a population with congenital
cataracts was deficient in the enzyme that participates in one of the synthesis steps of
lanosterol. A year later, Shanmugam et al.[31] tested lanosterol for the solubilization of
age-related cataracts in humans; however, they observed that the triterpenoid (used in the
dosage and protocol used by Zhao et al. to treat congenital cataracts) was inefficient in
the solubilization of senile cataracts. At the same time, Makley et al.[32] used differential
scanning calorimetry to determine the effect of approximately 2,500 compounds on the
melting temperature of the model heat shock protein Hsp27, which is similar to the aBcrystallin. A promising set of 32 sterols was checked for their binding capabilities to a
mutant of the aB-crystallin (R120G aB-crystallin). This mutation of aB-crystallin was
known to destabilize proteins in the lenses. Makley et al. also found that the most
promising compound (25-hydroxylcholesterol) increased transparency in mouse model
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cataracts. This 25-hydroxylcholesterol compound was bound to R120G aB-crystallin and
lowered its melting temperature (the temperature at which the protein unfolds). They
concluded that lanosterol was not a good candidate because of its low solubility and
marginal effect on the melting temperature of Hsp27; therefore, it was not included in the
final set of 32 sterols. These observations started a new chapter in cataract research.[33]
Following the studies of lanosterol and 25-hydroxycholesterol to restore lens’
transparency, other researchers tried to repeat those experiments or collect additional
experimental evidence about the activity of those sterols. Shen et.al. [34] found that, in
vitro, lanosterol (40 pM in M199 medium) delayed the occurrence of lens opacity in a
lanosterol synthase inhibited rat lens. Xu et.al.[35] used 20 pM lanosterol in 1% DMSO
to successfully reverse W151R mutant human pB2-crystallin aggregates. Kang et al. [36]
used all atom molecular dynamics simulation and free energy perturbation techniques to
show that lanosterol can bind to the hydrophobic interface of dimers of human yDcrystallin preventing aggregation. Daszynski et al.[37] failed to repeat the experiments by
Zhao et al.[30] and Markley et al[32] using their same approach. Also Daszynkski et
al.’s docking simulations shows those two sterols cannot bind to the groove which is
formed by the a-crystallin dimer using two wild types (PDB 2WJ7 and 2KLR) and a
R120G mutant (PDB 2Y1Z) aB-crystallin. Nagai et.al.[38, 39] used lanosterol
nanoparticles with a particle size distribution from 50 to 400 nm to repair the space and
structural collapse in the early stages in the lenses. They found that it delays the onset of
opacification of the lenses with a remarkable lens structure collapse and opacification,
but it does not repair them. They speculated that the repeated injection of lanosterol
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nanoparticles attenuated the manifestation of cataract-related factors and perhaps protects
the lenses from oxidative stresses.
A plausible explanation for the restoration of transparency in the lenses is the
fitting of lanosterol and 25-hydroxycholesterol into the interface of crystallin dimers.
Makley et al. [32] and Daszynski et al. [37] studied the possible interactions between 25hydroxycholesterol or lanosterol and the a-crystallin dimer interface by docking
simulations. Both of them predicted the Kd (dissociation constant that is the ligand
concentration at which half the protein molecules will have a ligand bound) of the two
sterols were in the high micromolar or even millimolar range; i.e. Kd values for
lanosterol-2KLR (wildtype aB-crystallin) and 25-hydroxycholesterol dimer interface
were 73.63 mM 25-hydroxycholesterol and 1.22 mM, respectively.[37] Daszynski et
al. [37] concluded that this high concentration of the two sterols could not be achieved
clinically in the lens.
a-crystallin exists in the lenses as a multimeric aggregate.[40] The aggregates
dissolve when stressed (a-crystallin is a member of the small heat shock protein’s family)
releasing dimeric aA-crystallins (aA-crystallin and aB-crystallin) that stabilize other
proteins, such as P- and y-crystallins,[41] in the lenses. Members of the sHsp are found
in all forms of life and have a highly conserved a-crystallin domain structure across
species. The sHsps are molecular chaperones that bind to unfolded or partially unfolded
proteins, preventing their interaction with other unstable proteins. Unfortunately, the
effect of sterols on the a-crystallin chaperone activity is not investigated.
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Evidence of cataract lens restoration only occurred in animals (dogs and rabbits).
The ineffectiveness in restoring human cataracts is the limitation of lanosterol solubility
in the delivery medium. Mixed solvents showed the ability to enhance lanosterol
solubility. The solubility of lanosterol is not reported in the open literature. A lanosterol
product datasheet from Cayman Chemical Company[42] reported that the lanosterol
solubility in ethanol and N,N-dimethylformamide (DMF) are 0.25mg/mL and 3 mg/mL,
respectively, but the temperature was not specified. Zhao et al. used 10-40 pM of
lanosterol in 1% DMSO that may contain undissolved lanosterol particles, which raises a
question that the crystallins aggregates interact with dissolved lanosterol or the
undissolved ones. . Access to solubility data for lanosterol is critical for its use to restore
crystallin aggregates, and it is also important for patient administration, especially
through eye drops.
In paper II, lanosterol solubility in organic solvent and water-alcohol binary
systems was measured first. A lab-built experiment set-up was used to measure lanosterol
solubility at different temperatures. It was found that lanosterol solubility increased with
increased temperatures, and it increased with increasing alcohol content. Lanosterol has
a low solubility in water at approximately 0.5 pM at 25oC and increased little with
increasing temperatures. The melting temperature and enthalpy of fusion for lanosterol
was also measured. Powder X-Ray diffraction (PXRD) was employed to monitor the
crystal form of the undissolved lanosterol. We demonstrated that aqueous solutions that
contained more than 0.5 pM lanosterol had undissolved lanosterol particles.
After collecting the lanosterol solubility data, a series of experiments were
performed using lanosterol,25-hydroxycholesterol and crystallins. Following the studies
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of lanosterol and 25-hydroxycholesterol, other researchers tried to repeat those
experiments and to study the mechanism of the restoration ability of the two sterols. The
effects of lanosterol and 25-hydroxycholesterol on the a-crystallin aggregation process
were not investigated in the available literature. If the compounds cannot inhibit protein
aggregation, they cannot solubilize aggregates. Furthermore, the influence of the two
sterols on the a-crystallin critical biological function and the chaperone activity were not
covered in previous researchers’ work.
In paper III, a series of experiments were conducted using bovine crystallins
isolated from raw bovine lenses. The aggregation kinetics of a-crystallin incubated with
lanosterol and 25-hydroxycholesterol with a concentration of 125 pM or lanosterol at 0.5
pM and of 25-hydroxycholesterol at 45 pM at 55oC were monitored by turbidity, high
performance liquid chromatography (HPLC), and Fourier-transform infrared
spectroscopy (FTIR). Then the chaperone activity of a-crystallin using y-crystallin as
substrates in the presence of those two sterols was evaluated using the same methods, but
the temperature was lowered to 50oC. The a-crystallin binding capacities of Cu2+ were
measured by the PAR colorimetric method and the bis-ANS fluorescence assay. Those
two sterols failed to prevent a-crystallin aggregation and could not enhance a-crystallin
chaperone activity regardless of concentration. FTIR and Circular dichroism (CD) results
showed that the secondary and tertiary structures of a-crystallin were not affected by the
sterols. Furthermore, the a-crystallin binding capacity of Cu2+ was not affected by those
two sterols.
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PAPER

I.
POLY (ETHYLENE) GLYCOL (PEG) PRECIPITATION OF
GLYCOSYLATED AND NON-GLYCOSYLATED MONOCLONAL
ANTIBODIES

ABSTRACT

The solubility of monoclonal antibodies (mAb) affects their production and their
intravenous administration to patients. In this work, the solubility of a fully glycosylated
and a non-glycosylated human mAb expressed in corn was studied by inducing their
precipitation by adding poly(ethylene) glycol (PEG). The experiments were done using
PEG 1,450 and 8,000 at concentrations ranging from 0 to 30 % w/w, at different pHs and
temperatures. Additional studies were performed in the presence of a Griffonia
(Bandeiraea) simplicifolia Lectin II, which binds to glycosylated proteins. These studies
clearly show that glycosylation increases the solubility of the antibody. These studies
also show that models based on excluded volume principles or on the statistical
correlation of solubilities are unable to capture the effect of glycosylation on protein
precipitation by PEG.

1. INTRODUCTION

In the past decades, monoclonal antibody (mAb) and mAb fragment-based drugs
have drawn great attention in the pharmaceutical industry because of their high target
specificity and therapeutic efficacy.[1] mAbs are glycoproteins, the glycan groups help

13

conserving the structure and function of the antibody. [2] Also the different types of
glycan groups make antibodies very heterogeneous. Moreover, the glycan groups affect
the immunological properties of antibodies by altering their affinity for Fc receptors.[3]
Antibodies glycosylated in vitro or in transgenic plants show greater diversity than their
in vivo counterpart and this diversity may differ from batch to batch, which causes some
batches not meeting specifications. A straightforward approach to eliminate this problem
is to shut down the glycosylation machinery altogether. Although the heterogeneity
problem is of course eliminated, the fact that the native and the non-glycosylated
antibodies are not exactly the same (in spite of both having the same biological activity)
raises questions about the solution stability (solubility) of the non-glycosylated
antibody.[4, 5]
Glycosylation may protect proteins from stresses that destabilize them such as
precipitants,[6-8] pH,[9, 10] chemicals,[11, 12] and heat.[10, 13] Destabilization of the
protein may lead to aggregation, which is a known phenomenon observed in commercial
antibodies preparations [14, 15] (particularly after reconstituting a freeze-dried sample).
The formation of biologically inactive aggregates decreases the solubility of the
preparation impeding their normal function. Moreover, there is evidence that protein
aggregates present in a protein drug may increase immunogenicity.[16] Because it has
been argued that glycosylation increases the stability of the protein, it is expected that a
non-glycosylated antibody will be more susceptible to aggregation.[3]
Proteins may be precipitated by manipulating the pH, temperature, ionic strength,
and the chemical composition of the solution.[17] Non-ionic polymers such as dextran
and poly(ethylene)glycol (PEG) can also be used to precipitate proteins.[18, 19] PEG is
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more effective than dextran[20] and the precipitation effectiveness increases with an
increase in the size of PEG; however, solutions containing high molecular weight PEG
(>10,000) are so viscous that they are not practical to use.[21]
PEG precipitation has been used, for example, for the crystallization of
glycosylated and non-glycosylated variants of agglutinin,[22] extraction of chicken IgY
from egg yolk,[23] precipitation of lysozyme,[24] and coupled with chromatography to
purify botulinum neurotoxin type B[25] among many other uses. In addition, PEG
precipitation has been used as a screening tool for developing high protein concentration
formulations.[26] Recently, a new method of continuous PEG precipitation followed by
tangential flow filtration was developed.[27] Such a method may be used to replace the
costly chromatography method (mostly Protein A based) in the downstream processes of
mAbs.
Two arguments have been used to explain the mechanism of protein precipitation
by non-ionic-polymers. The simplest one consists of considering that the presence of the
polymer decreases the volume of the solution available to the protein. This would force
the proteins to be closer to each other such as precipitate nuclei would form. The second
argument consists of considering that because of steric constraints the polymers are
excluded from the space separating two protein molecules. This particular distribution of
the polymer causes a “pressure imbalance” that pushes the proteins against each other.
Purely stearic arguments (argument 1) fail to explain the effect of the protein charge on
protein precipitation by non-ionic polymers. On the contrary, the second argument can
nicely (and rigorously) incorporate the effect of pH on protein precipitation by non-ionic
polymers.[18] Because both approaches assume that the solvent is a continuous fluid,
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they cannot capture the contribution of hydration forces to protein stability. For example,
water of hydration enters into Mahadevan-Hall’s[28] model as a contribution to the
volume of the molecule. The consequence of that is that the more hydrated the protein is
the more prone to precipitation it will be, which does not agree with experimental
evidence.
In this paper, the precipitation by the addition of PEG of a monoclonal antibody
expressed in corn was studied. Glycosylated and non-glycosylated samples of the same
antibody were used. The experimental parameters were PEG concentration and molecular
weight, pH and temperature. A few experiments were done with the addition of Griffonia
(Bandeiraea) simplicifolia Lectin II (GSL-II), which is a lectin[29] specific to the
GlcNAc group that is present in the corn-expressed antibody. The solubility data were
fitted with a Cohn[30, 31] salting-out equation analogous, and selected experiments were
compared with the theoretical models from Sim et al. ,[32] Odijk[33] and Atha and
Ingham.[18]

2. MATERIALS AND METHODS

2.1. GLYCOSYLATED MIXTURE AND NON-GLYCOSYLATED MAB
The mAbs were generously supplied by Monsanto Protein Technologies (St.
Louis, MO) or extracted from recombinant corn flour according to the procedure
described in Lee and Forciniti[34] and purified using a Protein A column. GSL-II, and
PEG of 8000 and 1450 Da were purchased from Sigma (St. Louis, MO). All the other
chemicals were of analytical grade. Two protein preparations were used: 1) a fully non-
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glycosylated mAb (we refer to this preparation as non-glycosylated) and 2) a mixture of
25% non-glycosylated, 50% single GlcNAc glycosylated mAb, and 25 % fully
glycosylated mAb (we refer to this preparation as glycosylated mixture).

2.2. PRECIPITATION EXPERIMENTS
0.31g of the glycosylated mixture or 0.61g of the non-glycosylated protein mAb
(or a total of 1.27mg each protein) were mixed in a centrifuge tube with various amounts
of a PEG stock solution (50% w/w of either PEG 1450 or PEG 8000) and phosphate
buffer at pH 6, TRIS buffer at pH 9, acetate buffer at pH 4, or carbonate-bicarbonate
buffer at pH 10.7 to complete 2.5 g. GSL II was added to some systems at a concentration
(in moles) similar to that of the mAb. The contents of the tubes were mixed in an orbital
mixer for 20 minutes and then centrifuged at either 4 °C, 25 °C, or 40 °C for 90 minutes
at 2,800 xg. Samples of the supernatant were removed and absorbance at 280 nm was
measured in a double beam spectrophotometer. Appropriate blanks were prepared each
time and their absorbance values were discounted from the samples’ reading. For the
systems containing lectins, the precipitate was re-suspended in the appropriate buffer and
run through a gel permeation column using a UV detector in tandem with the MALS
detector.

2.3. MULTIPLE ANGLE LASER LIGHT SCATTERING (MALS)
Samples of the glycosylated and non-glycosylated mAb were injected through a
50 pL or a 250 pL loop into a gel permeation column (Protein KW-803, Shodex). Two
detectors were connected in series: 1) a Hitachi UV spectrophotometer and 2) a Wyatt
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multiple angle laser light scattering detector. The flow rate was either 1 ml/min or 0.5
ml/min. The same procedure was followed with re-suspended precipitates of the
antibodies in the presence of lectins.
The extinction coefficients of the glycosylated and non-glycosylated mAbs were
determined as e= 1.37 cm2/mg and s = 1.15 cm2/mg, respectively.[34] The molecular
weight of the proteins was determined by the Debye plotting of the scattering data using
an internal calibration constant for the UV detector.

2.4. EXPERIMENTAL DESIGN
A full two-level experimental design was used. The factors included pH (6 and 9),
glycosylation of the mAb (glycosylated and non-glycosylated) and PEG molecular
weight (8,000 and 1450). Additional experiments were performed at 5, 25 and 40 oC and
in the presence of GSL-II.

2.5. THEORETICAL BACKGROUND
A semi-logarithmic analogous to the Cohn salting-out equation was suggested by
Juckes[31] to correlate protein solubility with PEG concentration,
log S = p<a + K

(1)

where S is protein solubility, rn is the PEG concentration in % w/w, and k is the log of the
intrinsic solubility of the protein in the absence of PEG. The ^-value that represents the
precipitation efficiency can be obtained by fitting the linear region of the solubility data
with Eq.1.
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Differentiating Eq. 1 with respect to the polymer concentration yields,
d log S = A log S =
da
Aa

(2 )

Using the depletion theory of nanoparticles immersed in a semi dilute polymer
solution, Odijk[33] derived an expression for p in terms of hydrodynamic radius of the
protein (rh.prot),
A log S
= P = -0.036rth, p r o t
Aa

(3)

Another model for p was proposed by Atha and Ingham.[18] Their model is based
on excluded volume considerations and yields the following expression for p:
a
-P

(4)

0.23Mo

where M 2 is the molecular weight of PEG, and a is the interaction coefficient between
protein and polymer, which can be calculated by the expression of molar excluded
covolume for pairs of spherical molecules 2-3 as proposed by Ogston,[35]
U 23 = 1 0 3 =

4nN
^

)3
(rh
h,, p r o t

‘ h ,P E G

(5)

where U23 is the molar excluded covolume for pairs of spherical molecules 2-3, N is
Avogadro’s number, and r h,PEG is the hydrodynamic radius of PEG.
Based on previous works,[18, 33, 36-38] Sim et al. [32] proposed a model for p
that includes the hydrodynamic radius of protein (rhprot) and PEG (rh,PEG),
P =

rhJPEG + $ ) rh,prot

(6)

where y and S are regression parameters. The first term (yrlPEa rh,prot) was interpreted by
Sim et al. as the depletion of protein by PEG whereas the second term (5 rh,prot) accounts
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for the volume excluded by the protein and the depletion of PEG by the protein. This
depletion of PEG by protein allows the protein to remain soluble. They regressed data for
6 different proteins with PEGs of three molecular weights at each protein’s isoelectric
point.[39] Regression of the experimental data sets yielded the following correlation for
( with the radius of the polymer and the protein,[39]
A = (0.076S

- 0.045)rhprot.

(7)

The regression was not very good as evidenced by a correlation coefficient of
R2=0.725. Compared to Atha and Ingham’s model, Sim’s model is a simple correlation
for protein solubility with PEG and protein sizes, but it is based on fundamental
principles of polymer physics.
All three models need the hydrodynamic radius of protein (rh,prot) and PEG
(rh,PEG) to calculate the (-value. In this study the r h,PEG was calculated using the
correlation by Fee et a/.,[36]
rKpEG = 0.1912MPEG

(8)

The r h,prot of both proteins was determined using the molecular weights obtained
from the MALS results assuming globular proteins (molecular weight: 150 kDa and
r h,prot= 5.3 nm).

3. RESULTS AND DISCUSSION

We first determined the precipitation of the mAb solutions in the absence of PEG.
Measurements of protein concentration after centrifugation of the standard solutions were
done after 20 min., 2.5, 12, 24, and 36 hours for selected systems (pH 4, pH 6, pH 10.7,
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and pH 6 with GSL II) in the absence of PEG. The decrease in the solubility of the
glycosylated sample was between 0.1 to 7% after 36 hrs. On the contrary, the decrease in
the solubility of the non-glycosylated mAb ranged from 0.1% (pH 6 plus GSL II) to 40 %
(pH 10) also after 36 hrs. The presence of the lectin seems to stabilize the nonglycosylated mAb. The isoelectric point of the non-glycosylated mAb is from 9.7 to 9.1
whereas the isoelectric point of the glycosylated mixture expands the range from 9.4 to
8.7[34, 40]. Near its isoelectric point, the non-glycosylated mAb solution becomes quite
unstable after 24 hours. The experiments containing PEG were done using an incubation
time of 20 minutes.

Figure 1. Effect of PEG molecular weight, pH and temperature on the solubility of mAbs.
‘G’ or ‘NG’ represent glycosylated mixture and non-glycosylated mAbs in the legend and
marks ^ is the onset precipitation concentration of PEG. Panel A. effect of PEG
molecular weight. Panel B, pH effect in PEG 8000. Panel C, effect of pH at PEG 1450.
Panel D, effect of pH at pHs which are more away from pIs. Panel E and F, effect of
temperature
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Figure 2. Effect of Griffonia (Bandeiraea) simplicifolia Lectin II (GSL II) on the
solubility of mAbs upon addition of PEG 8000. The dashed lines are used to show a twostep precipitation process. Panel A: pH 4. Panel B: pH 6. Panel C: pH 10.7

Plots of antibody solubility vs. polymer concentration at different conditions are
shown in Figures 1 and 2. “G” and “NG” in the figures represent the glycosylated
mixture and the non-glycosylated mAb, respectively. Figure 1 shows the effect of pH,
PEG molecular weight and temperature and Figure 2 shows the effect of the addition of a
lectin on the solubility of the mAbs. Figure 1A shows that both preparations are more
soluble in PEG 1450 than PEG 8000. Both preparations are more soluble at pH 6 than 9
in the presence of either PEG 1450 or PEG 8000. At very acidic (pH 4) or very basic (pH
10.7) pHs the solubility of both preparations increases but the solubility of the
glycosylated mAb is more sensitive to pH changes. The results obtained at pH 10.7 are
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striking since the glycosylated mAb does not precipitate in the PEG concentration range
covered by these experiments, in spite of the fact of containing 25% of the nonglycosylated protein. At the highest PEG concentration used to precipitate the nonglycosylated mAb (24% w/w) approximately 25% of the antibody remains in solution;
which may explain the absence of precipitation at pH 10.7. Figure 1E and F show the
effect of temperature on the solubility of the mAb in the presence of PEG. At 4°C and at
a PEG concentration of 12% only 1% of the non-glycosylated mAb remains in solution
whereas about 8% of the glycosylated mixture remains in solution at the same conditions.
Finally, Figure 3 shows that the precipitation of the mAbs in the presence of a lectin
follows a two-step process at pH 4 and 6. The precipitation curves were fitted with a
Cohn salting-out equation analogous (Eq.1) to obtain the precipitation efficiency
coefficient, fi. The m*-values (the PEG concentration at the onset of precipitation) where
calculated from the intercept of the Cohn equation with a horizontal line at the initial
protein concentration.

3.1. m* VALUES
The m* values for all runs are shown in Table 1 and in Figure 3. Figure 3A
shows that, with a few exceptions, the value of m* is larger for the glycosylated than for
the non-glycosylated mAb. The difference in the m*-value of the glycosylated mixture
and non-glycosylated mAb is more pronounced at pH 4 and PEG 8000 (Figure 3B and
C). This confirms that one of the roles played by the carbohydrates chains is to increase
protein solubility. The m*-values of both preparations decrease as the temperature
decreases as expected.
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Table 1. m*-values and ^-values of glycosylated mAb mixture and non-glycosylated
MAb precipitation curves
PEG/Da

1450
1450
8000
8000
8000
8000
8000
8000

pH

6
9
4
6
9
10.
7
6
6

T/oC

Addi
tive

Glycosylated mixture

Non-Glycosylated MAb

25
25
25
25
25

N/A
N/A
N/A
N/A
N/A

P-value
-0.16±0.008
-0.14±0.007
-0.20 ± 0.02
-0.14 ± 0.01
-0.12 ± 0.02

25

N/A

0

N/A

-0.19 4 0.02

15.340.9

4
40

N/A
N/A

-0.184
-0.11 ± 0.02

6.09
8.640.4

-0.429
-0.153

7.78
9.96

1st

2nd

m*-value
22.4640.2
14.140.1
18.840.8
8.440.2
8.040.3

P-value
-0.3140.02
-0.2240.008
-0.283 4 0.004
-0.248 4 0.007
-0.22 4 0.02

m*-value
21.640.2
13.3140.1
13.940.1
8.740.3
8.440.4

1st

2nd

1st

4

25

GS
L II

-0.0086
± 0.002

-0.087
± 0.01

2
2

7.9
±0
4

-0.021

8000

8000

6

25

GS
L II

-0.1

-0.2

4.5

7.1
1

-0.064

8000

10.
7

25

GS
L II

0

0

N/A

4 0001

-0.034
4 0.009

2nd

1st

2nd

4-012
0.03

2.9
40.

8.2
40.

0.24
1

5.1

6.8
4

N/A

9.0
40. N/A

To identify the main effects on the m*-values, a Paretto chart (Figure 3D) was
constructed using three experimental factors: 1) type of mAb, 2) PEG molecular weight
and 3) pH. The most significant factor is the molecular weight of PEG whereas the
presence of the glycan groups is less statistically significant on the onset of precipitation.
Recently, a quantitative structure-activity relationship (QSAR) [41] model was used to
correlate the experimental m*-values and ^-values with 132 molecular descriptors. The
coefficient of determination R2 for m*-values is 0.9 and for ^-values is 0.93.
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non-glycosylated m'-value

T e m p e ra ture(°C )

Figure 3. m*-values.Panel A. Comparison of m*-values of both mAb preparations.
Panels B (PEG Mw 8000) and C (PEG Mw1450). pH dependence of the m*-values; ■ ,
glycosylated mAb; • , non-glycosylated mAb. Panel D. Paretto chart for m*-values. PEG
molecular weights: 1450 or 8000Da, pHs: 4 or 6, and both types of mAbs. Panel E,
Effect of temperature on m*-value

That study paves the way to explain protein precipitation by PEG based on
protein surface properties. The 10 molecular descriptors with highest variable of the
influence on the projection (VIP) of m*-values are shown in Table 2 in decreasing order
of importance. The direction of the influence of each factor on m*-value is given by the
sign of the regression coefficient i.e., an increase in a molecular descriptor with a positive
(+) regression coefficient will increase the amount of PEG per protein needed to start
protein precipitation and vice versa. [41] They concluded that there are four major factors
that can influence m*-values: the sphericity of the protein (-)> density of the protein (+)>
electrostatic surface potential (ESP) (+)> solvent accessible surface area of protein (+).
The ESP is easily manipulated by changing the pH of the solution. Still, there may be an
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indirect effect of the carbohydrate chain on the ESP since its presence may affect the
dissociation constant of ionizable amino acids side chains. The ESP of a protein will
increase as the solution pH is farther away from the protein’s isoelectric point. Therefore,
the amount of PEG needed to precipitate the protein will increase as the ESP increases,
which agrees with our finding for both preparations with PEG 8000 and PEG 1450. The
effect of pH for the whole design is somehow masked by the dominance of PEG
molecular weight. The sphericity and density of the proteins barely change upon
glycosylation. However, glycosylation does increase the solvent accessible surface area
of protein.[42] Because the regression coefficient for solvent accessible surface area is
positive and the glycosylated protein has a larger surface area, the onset of precipitation
should happen at a higher PEG concentration for the glycosylated sample, as observed.
However, the effect is not statistically significant at 95% confidence.

Table 2. Descriptors with a VIP value >1.0 included in the final QSAR model for m*value and their descriptiona
No.

Descriptor

Definition

Sign of
Regression
coefficient*123

shapeMin

Value for the sphericity of the
protein:(minimum distance between
mass center and protein surface)/(mean
distance between mass center and
protein surface)

-

dens

Density of the protein

+

sumSurfA_ShellEsp

Sum of ESP of surface points projected
on a shell around the molecule with a
distance of 5A

+

1

2

3
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Table 2. Descriptors with a VIP value >1.0 included in the final QSAR model for m*value and their descriptiona (cont.)

No.

Descriptor
totalSurf_patchEsp

4
toalSurfA_Shell
5
totalSurf_PatchHyd
6

Definition

Sign of
Regression
coefficient

Solvent-accessible surface area of
protein in A2 on the patch with the
highest ESP value

+

Solvent-accessible surface area of a
shell around the molecule with a
distance of 5 A

+

Solvent-accessible surface area of the
protein surface patch with the highest
hydrophobicity value in A2

+

7

nAAcid

Chain length of the protein

+

8

mAtom

Number of atoms of the protein

+

9

mass

Molecular mass of the molecule

+

devA_PlaneEsp

(maximum ESP value-minimum ESP
value)/mean value of ESP on the plane
with the highest ESP value

-

10

aReproduced with permission from reference 33

3.2. p-VALUES
The fi-values and associated errors of all runs are presented in Table 1 and plotted
in Figure 4. The number of data points in some of the runs is too small and therefore
errors in the fitting cannot be calculated. In all runs (even in the lectin containing runs)
the fi-values are more negative for the non-glycosylated mAb than for the glycosylated
mAb, which indicates that PEG is more efficient precipitating the non-glycosylated mAb.
At the same pH, the higher the molecular weight of PEG the higher the efficiency to
precipitate both the glycosylated and non-glycosylated mAbs. At the same PEG
molecular weight, the efficiency decreases with increasing pH (Figure 4B and C). The fi-
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values for the glycosylated mAb at pH 10.7 with the addition of PEG 8000 was set to
zero because the glycosylated mAb cannot be precipitated in the PEG concentration
studied. In the presence of PEG 8000 at pH 6, the efficiency increases with decreasing
temperature for both samples (Figure 4E) but the solubility of the non-glycosylated mAb
is more sensitive to changes in temperature than the glycosylated one(Figure 5E). For
example, at 12% PEG, nearly 70% of the non-glycosylated protein remains in solution at
40 oC whereas only 1% remains in solution at 4 oC.

Figure 4. ^-values for the entire experimental base. Panel A, comparison of ^-values of
the glycosylated and non-glycosylated mAb. ■ , glycosylated mAb; • , non-glycosylated
mAb. Panels B (PEG 8000) and C (PEG 1450). ^-values of glycosylated and nonglycosylated mAb vs. pH; ■ , glycosylated mAb; • , non-glycosylated mAb. Panel D:
Paretto chart of ^-values. PEG molecular weights: 1450 or 8000Da; pHs: 4 or 6. Panel E:
effect of temperature on ^-values. ■ , glycosylated mAb; • , non-glycosylated mAb
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A Paretto chart was constructed using three experimental factors: 1) type of mAb,
2) PEG molecular weight and 3) pH. Figure 4D shows that the effect of those factors on fi
is in the order: glycosylated or non-glycosylated> pH >PEG molecular weight. This
order is opposite to the order observed for the onset of precipitation. The Paretto chart
shows that the effect of the presence of carbohydrates chain on fi is more important than
the effects of pH (associated with electrostatic repulsions). Therefore, although
glycosylation has a moderate effect on the onset of precipitation it has a dominant effect
on the precipitation efficiency by PEG.
The trends in the fi-values of all runs without GSL-II were analyzed in the context
of the three models introduced earlier (Figure 5). The hydrodynamic radii of PEG used in
the models were calculated using Eq.8 whereas the hydrodynamic radii of the proteins
were measured using MALS. All three models show that the fi-values increase with an
increase in the protein hydrodynamic radius and PEG molecular weight.

Figure 5. Comparison of fi-values of selected runs with three predictive models.Panels A
(glycosylated mAb) and B (non-glycosylated mAb): fi-values vs. PEG MW. Panels C
(PEG MW 1450 Da) and D (PEG MW 8000 Da): fi-values vs. protein radius. Inserts are
zoom outs of the plots
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The predicted ^-values of the glycosylated and non-glycosylated mAbs in Odijk’s
and Sim’s models are similar to the experimental ones, but Atha and Ingham’s model
overestimates those ^-values. The glycosylated mAb has a slightly larger molecular
weight/hydrodynamic radius, which should yield higher ^-values. Both Odijk’s and
Atha’s models are based on excluded volume considerations. Whereas Atha’s model
assumes that protein and polymer are hard bodies (spheres and cylindrical fibers) Odijk’s
model assumes that the polymer is a chain of monomers and that particles are of arbitrary
shape but have an equivalent radius of gyration. By incorporating the hydrodynamic
radius of PEG and the Stokes radius of the protein, Sim’s model provides a quick
guideline to select precipitation conditions by PEG. Our experimental data show that pH
has an effect on the ^-values that cannot be explained by any of the three models.
Furthermore, all three models predict an opposite trend for the ^-values of glycosylated
and non-glycosylated mAbs. Although the carbohydrate chain on the glycosylated mAb
surface and its associated water shell increase the hydrodynamic radius, it does not
promotes precipitation. On the contrary, the carbohydrate chain increases protein’s
solubility. We argue that these models fail because they do not account for electrostatic
repulsions/attraction and for hydration forces (enhanced by the presence of glycan
groups). Enhanced hydration may justify the higher stability of the glycosylated mAb.
We also compared the ^-values with the predictions of the QSAR model. The 19
molecular descriptors with highest variable influence on the projection (VIP) values are
shown in Table 3 in descending order. As before, the direction of the influence of each
factor on ^-values is given by the sign of the regression coefficient i.e., an increase in a
molecular descriptor with a negative (-) regression coefficient makes the precipitation
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curve steeper and vice versa. Hammerling et al. [41] found that the three most effective
factors affecting ( are solvent accessible surface area of protein (-) > protein molecular
weight (-), number of atoms and chain length of the protein (-) > electrostatic surface
potential (-).

Table 3. Descriptors with a VIP value >1.0 included in the final QSAR model for ( 
value and their descriptiona

No.

Descriptor

totalSurf
1

Definition

Sign
of
Regres
sion
coeffic
ient

Solvent accessible surface area of protein in
A2

-

2

mass

Molecular weight of the molecule

-

3

nAtom

number of atoms of the protein

-

4

nAAcid

Chain length of the protein

-

5

shapeFactor

Value for the sphericity of the protein

-

sumNeg_PatchEsp

Sum of negative ESP on the protein patch
with the highest ESP value

+

sumNeg_SurfEsp

Sum of negative ESP on the protein surface

+

median_PlaneESP

Median value of ESP on the protein patch
with the highest ESP value

-

sum of ESP of surface points on the protein
patch with the highest ESP value

+

Sum of ESP of surface point on the protein
surface

+

Solvent accessible surface area of the protein
patch with the highest ESP value

-

6
7
8
sumSurf_PatchEsp
9
sum_SurfEsp
10
totalSurf_PatchEsp
11
12

ninAbs_SurfHyd_4 Number of points with low hydrophobicity on
the protein surface
sumPos_SurfHyd

13

Sum of points with positive hydropathy score
on the protein surface

-
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Table 3. Descriptors with a VIP value >1.0 included in the final QSAR model for fivalue and their description (cont.)

No.

Definition

Descriptor

devA_PatchHyd

14

Sign
of
Regres
sion
coeffic
ient

(maximum hydrophobicity value-minimum
hydrophobicity value)/mean value of
hydrophobicity on the patch with the highest
hydrophobicity

binAbs_SurfHyd_3 Number of points with low hydrophobicity on
the protein surface
15
16

charge

overall charge of protein

median_ShellEsp

+

Median value of ESP projected on a
shell around the molecule with a distance of 5

17
max_PatchHyd
18
sumNeg_SurfHyd
19

A

-

Maximum value hydrophobicity on the
protein patch with the highest hydrophobicity
value

+

Sum of negative hydrophobicity values on the
protein surface

+

aReproduced with permission from reference 33
These trends agree with Atha and Ingham’s[18] findings that larger proteins will
have a steeper slope; i.e., the larger the molecular weight of the protein the higher the
possibility of protein-protein interaction. This conclusion is contradicted by the findings
of Sola et al. [43] who found that glycosylation enhances the stability of a-chymotrypsin
because glycosylation increases the solvent accessible surface area linearly. In the QSAR
model, the increased solvent accessible surface area is the result of an increasing number
of hydrophilic amino acids in the polypeptide chain whereas in Sola et al.’s experiments
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it is caused by glycosylation. Glycosylation will increase the solvent accessible surface
area without affecting the size of the protein as much as hydrophilic amino acids. For
example, arginine, the most hydrophilic amino acid residue, increases the solvent
accessible surface area by ~1.2 A2/Da[44] but a typical glycan group like lactose will
increase the area by ~1.5 A2/Da. The QSAR model cannot capture the carbohydrate
chain’s effects on PEG-induced precipitation. This should not be surprising since the
model does not include the same protein with and without glycan groups in the study and
the glycan groups of the glycoproteins were not included in the MD simulation. The
glycosylated mAb used in our experiments has a larger molecular weight and a larger
solvent accessible surface area than the non-glycosylated mAb, but it has a flatter slope
than the non-glycosylated counterpart, which contradicts the QSAR model. We argue that
the solvent accessible surface area itself should not be used as one of the indicators of
protein stability. Instead, solvent mediated forces, like hydration ones, would be a better
predictor. The presence of glycan groups in a protein stabilizes the polypeptide chain by
increasing its hydration. Protein stabilization caused by hydration forces is, in part,
compensated by the destabilization caused by an increase in protein molecular size.

3.3. ADDITION OF LECTINS
Figure 2 shows that the addition of GSL-II produces a two-stage precipitation
pattern at pH 4 and 6. The pattern consists of a first stage in which there is gentle
decrease in the solubility followed by a second stage in which the solubility decreases
sharply (Figure 2 dash line). Two mechanisms may be considered here: 1) GSL-II is not
specific to non-glycosylated mAb, but it still lowers the m*-value sharply, which implies
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that the non-glycosylated mAb co-precipitated with GSL-II by adding PEG. The
enhanced co-precipitation by PEG or hetero-interaction among variant proteins was
reported by Miekka and Ingham. [45] They argue that it only occurs when the hetero
complex is already present in the solution before PEG is added (proteins forming hetero
complex before adding PEG). 2) GSL-II specifically binds to the mono-glycosylated
mAb in the mixture, and that is the species that precipitates. Co-precipitation may also
occur in the glycosylated mixture since 25% of mAb is non-glycosylated. Miekka and
Ingham[45] also pointed out that the electrostatic interactions between proteins are the
main reason of forming hetero-complex; i.e., the enhancement of co-precipitation in
binary mixtures was a maximum at the pH intermediate between the two isoelectric
points of the proteins (the proteins carried opposite net charge). Considering the
isoelectric point of the mAb and the lectin, the hetero-complex should be more stable at
pH 6 than at pH 4. In the next two paragraphs, the second precipitation stage is discussed
in more detail.

Figure 6. The m*-values and ^-values vs. pH for the precipitation curves with GSL-II and
PEG 8000.Panels A (glycosylated mAb) and B (non-glycosylated mAb): comparison of
the m*-values of precipitation curves with or without GSL-II. Panel C: comparison of
the ^-values of glycosylated mAb and non-glycosylated mAb in the presence and absence
of GSL-II
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The addition of GLS-II decreases the m*-value of both preparations (Figure 6A
and B) and the effect is more pronounced at pH 6 where both the mAb and the lectin (pI:
5.6~6) are positively charged. More importantly, pH 6 is in the middle the optimum
binding pH range of GSL-II and GlcNAc is 4.2 ~8.8.[46] At the same pH (pH 4 and pH
6), the m*-values of the glycosylated mAb are slightly smaller than the ones for the nonglycosylated mAb’s in the presence of GSL-II. Still, at pH 10.7, the glycosylated mixture
cannot be precipitated even in the presence of GLS-II. pH 10.7 is outside GSL-II’s
optimum binding pH range; and therefore its presence did not affect the anomalous
behavior observed with the pure mAb at this pH.
The first stage absolute ^-values are smaller than the second stage ^-values (Table
1). The second stage ^-values are around -0.087~ -0.12 for pH 4 and -0.20~ -0.24 for pH
6 with and without GSL-II, respectively. The second stage P-values for both mAbs in the
presence of GSL-II show a minimum at pH 6, which indicate that the PEG precipitation
efficiency is highest at that pH. The enhancement of precipitation efficiency at pH 6 for
both mAbs may be caused by the proximity of that pH to the isoelectric point of GSL-II
(Ip 5.6~6.0). Because GSL-II also binds to GlcNAc, the differences in P-values of the
glycosylated mAb with and without GSL-II are larger than for the non-glycosylated one.
GSL-II lowers the PEG precipitation efficiency of the non-glycosylated mAb at all pHs
but especially at pHs 4 and 10.7. Both the lectin and the mAb are either positively (pH 4)
or negatively charged (pH 10.7) at those pHs and therefore electrostatic repulsions are
strengthened. The same observation can be made for the glycosylated mAb at pH 4 and
10.7. Once again, even in the presence of the lectin the glycosylated mAb does not
precipitate in the range of PEG concentrations used in this study. GSL-II decreases the
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differences in the precipitation efficiency in between both preparations at all pHs. This is
expected because the stability provided by the carbohydrate chains is lost as the lectin
binds the mAb.

Figure 7. Chromatograms of the re-suspended precipitates in the presence of a
lectin.Panel A: non-glycosylated mAb at 16.6 % precipitation. Panel B: glycosylated
mAb at 29.6 % precipitation. Panel C: non-glycosylated mAb at 46.3 % precipitation.
Panel D: glycosylated mAb at 65.3% precipitation

There are some differences in the precipitation pattern of the non-glycosylated
protein and the glycosylated mixture and between the composition of the precipitate at
the beginning of the precipitation and at the end (Figure 7) in the presence of GSL-II. At
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the onset of precipitation (Figures 7 A and B) there are no major differences in the
composition of the non-glycosylated and glycosylated mAb precipitates. However, in the
middle of the precipitation curve (Figures 7 C and D) the precipitate of the nonglycosylated mAb is richer in the lectin (peak at ~ 9 ml) than the corresponding
precipitate of the glycosylated one. Base on the HPLC-MALS results and recalling the
co-precipitation mechanism, the first stage may represent the precipitation of hetero
complex which is larger than glycosylated or non-glycosylated mAb, the second stage
represents the free mAbs or the GSL-II-GlcNAc-mAb complex. For both systems C and
D there is a portion of the precipitate that cannot be re-suspended. We speculate that this
precipitate consists of aggregates of the lectin with the GlcNAc glycosylated mAb. The
two-stage pattern disappeared in the non-glycosylated mAb precipitation curve at pH
10.7, which implies the hetero-complex cannot be formed because both of the nonglycosylated mAb and GSL-II are negatively charged.

4. CONCLUSIONS

The results presented in this paper demonstrate the differences in the solubility of
the glycosylated and non-glycosylated mAbs. PEG has lower precipitation efficiency and
a larger onset concentration for the non-glycosylated than for the glycosylated mixture.
This manuscript demonstrates that depletion and electrostatic forces are not sufficient to
explain protein precipitation by PEG. The precipitation experiments with lectin show that
there is a complex interplay between the mAbs and GSL-II. This is demonstrated by the
analysis of the precipitates in the presence of a lectin. Our studies also show that
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available models to correlate or predict protein solubilities are unable to capture the effect
of glycosylation on protein solubility.
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II. SOLUBILITY OF LANOSTEROL IN ORGANIC SOLVENTS AND IN
WATER-ALCOHOL MIXTURES AT 101.8 KPA

ABSTRACT

Lanosterol is a sterol derivative whose physicochemical properties are poorly
understood. Pure lanosterol (>95%) was isolated from a crude product (54.6%) by a
newly developed C18 reverse-phase high-performance liquid chromatography (HPLC)
method. Purity and structure were confirmed by gas chromatography-mass spectrometry
(GC-MS). The melting temperature and fusion enthalpy were determined to be 408.27 K
and 23.61 kJ-mol-1, respectively. The solubility of lanosterol was measured in methanol,
ethanol, acetonitrile, acetone, N,N-dimethylformamide (DMF), dimethyl sulfoxide
(DMSO), ethyl acetate, isopropanol, w-propanol, water and binary system, watermethanol, water-isopropanol and water-ethanol using a static equilibrium set up from
278.09 K to 338.78 K. The solubility of lanosterol increases with an increase in
temperature. The mole fraction solubility of lanosterol in organic solvents has a minimum
of 3.00*10-5in methanol at 277.78 K and a maximum of 0.0048 in w-propanol at 318.93
K. The solubility of lanosterol in organic solvents and in water-alcohol mixtures were
correlated by the modified Apelblat equation and by the Wilson, NRTL, and UNIQUAC
models. In addition, the binary water-alcohol systems were correlated with ApelblatJouyban-Acree model and van’t Hoff-Jouyban-Acree.
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1. INTRODUCTION

Lanosterol was first discovered in the non-saponifiable portion of lanolin. It is a
tetracyclic triterpenoid that is synthesized in plants, animals and yeast.[1] It is also an
intermediate in the biosynthesis of cholesterol.[2] Lanosterol inhibits the formation of
paraneoplastic lesions in the colon of rat.[3] A side chain derivative of lanosterol (3Phydroxy-5a-lanosta-8, 24-diene) acts as an inhibitor of A24 (25) sterol methyl
transferase.[4] Lanosterol demethylase, 14-a-demethylase, is the primary target of
antifungal drug.[5-7]In addition, besides its biochemical activity, lanosterol is the starting
material of other steroids.[8]
The traditional isolation methods of lanosterol involve toxic or hazardous reagents
like mercury (II) acetate and Li Al H4.[9] Even though an environment-friendly routine
has been reported recently,[10] it also requires a relative long isolation process and
experienced operators.
Recently, lanosterol has been found to dissolve protein aggregates in
cataracts.[11] Unfortunately, the restoration of the affected lens only happened in animals
(dogs and rabbits).[11] It has been argued that its ineffectiveness to reverse human
cataracts is caused by the limited solubility of lanosterol in the delivery medium.[12] One
means to increase the solubility of lanosterol is to use mixed-solvents. To the best of our
knowledge, the solubility of lanosterol has not been previously reported in the open
literature. We did find a product data sheet from Cayman Chemical Company.[13] They
reported a solubility of lanosterol of 0.25 mg/ml and 3 mg/ml in ethanol and DMF
respectively. The temperature was not specified.
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In this report we present a new, fast and environmentally friendly purification
process for lanosterol. This new method would make large amounts of highly pure sterol
readily available. The solubility of the purified product was experimentally studied in
acetone, acetonitrile, N,N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), ethyl
acetate, ethanol, methanol, isopropanol, n-propanol and binary water-methanol, waterisopropanol and water-ethanol mixtures as a function of temperature at 101.8 kPa.

2. EXPERIMENTAL METHODS

2.1. MATERIALS
Crude lanosterol with a purity of 54.6% was purchased from Steraloids Inc.
(Newport, IR). Crude lanosterol was purified with a Pre-RP-HPLC column and its purity
was confirmed by gas-chromatography-mass-spectroscopy (GC-MS). Ultrafiltered type 1
water (>18.0 MOhm/cm) was utilized as obtained from a Nanopure water system
(Barnstead). Acetone, acetonitrile, DMF, DMSO, ethyl acetate, ethanol, isopropanol, npropanol and methanol were ACS grade or better. All solvents were used “as received”
without further purification. Details of solvents were summarized in Table 1.

Table 1. Sources and Mass Fraction Purity of Materials
Source

%
purit
y

Purificatio
n method

Analysis
method

79-630

Steraloid
s Inc.

>95.
0

prep-RFHPLCd

GCb

67-56
1

Alfa
Aesar

>99.
8

none

GC

Chemical name

CAS
number

lanosta-8,24-dien-3 ol (Lanosterol)
Methanol

Solvent
group

protic
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Table 1. Sources and Mass Fraction Purity of Materials (cont.)
Chemical name
Ethanol (200 proof)
Propan-2-ol
(Isopropanol)
Propan-1-ol(«Propanol)
Propan-2-one
(Acetone)
Acetonitrile
N,NDimethylmethanami
de (DMF)
Dimethyl sulfoxide
(DMSO)

CAS
number

Source

64-17
5
67-63
0
71-23
8
67-64
1
75-05
8

Fisher
Scientific
Fisher
Scientific

68-12
2

Fisher
Scientific

67-68
5
141
Ethyl Acetate
78-6
a Provided by the suppliers.

Aldrich
Aldrich
Aldrich

%
purit
y
>99.
5
>99.
5
>99.
7

Purificatio
n method

Analysis
method

Solvent
group

none

GC

protic

none

GC

protic

none

GC

protic

99.8

none

GC

aprotic

99.9

none

GC

aprotic

99.9

none

GC

aprotic

none

GC- FIDc aprotic

none

GC

Fisher
99.9
Scientific
Fisher
>99.
Chemical 5

aprotic

b Gas chromatography.
c Gas chromatography with flame ionization detector.
d Preparative reverse-phase high-performance liquid chromatography.

2.2. EXPERIMENTAL APPARATUS FOR SOLUBILITY DETERMINATION
The apparatus consists of a 25 mL three-neck glass flask with a water jacket to
maintain the temperature. An Amporbe TMD-52 K-type thermocouple (Everett, WA)
with a standard uncertainty of 0.01 K was used to monitor the solvent’s temperature in
the glass flask. In order to keep atmospheric pressure and avoid solvent evaporation, a
condenser was coupled to the glass flask. Magnetic stirrers were used in the water jacket
and the flask to keep homogeneous temperature and lanosterol concentration. The
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temperature in the water jacket was maintained by a Polyscience 9102 circulating bath
(Niles, Illinois) with a temperature stability of 0.01 K. The schematic diagram of the
experimental set up is shown in Figure S1.

2.3. ISOLATION OF LANOSTEROL
Crude lanosterol is a light yellow powder with a purity of 54.6% according to the
manufacturer. The reverse phase chromatographic separation was done in an AKTA
purifier system with an Agilent Eclipse XDB-C18 column (4.6mm*150mm). The mobile
phase was methanol at a flow rate of 2 mL/min, the injection loop was 1mL, and the UV
detector was set at 215nm. The lanosterol and dihydrolanosterol fractions were collected
by a fraction collector. Fractions were pooled and vacuum-oven-dried before stored in a
desiccator. Pure lanosterol and dihydrolanosterol are white powders.
The purity and identification of lanosterol and dihydrolanoterol were confirmed
by an Agilent 7890B gas chromatography system with HP-5MS (Agilent Scientific,
USA) capillary column (30m length*0.25mm I.D.0.25mm film thickness) and an Agilent
5977B mass selective detector (MSD). The carrier gas was helium (>99.999%) with a
constant flow rate of 1 mL/min. The injection was in split-less-mode at 260 oC with a 20
min solvent delay and an injection volume of 1pL. The column oven temperature
program was set at 150 °C for the first 2 min, ramped to 230 °C (25 °C/min) further on to
248 °C (1.0 °C/min) and finally to 325 °C (25 °C/min) with a 3.7 min hold. The transfer
line temperature was set at 300 oC. The MSD analyzer was set at 70 eV and the electron
impact source temperature was 230 oC.
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2.4. THERMAL ANALYSIS
The melting temperature and enthalpy of fusion of lanosterol were determined by
a Q2000 Differential Scanning Calorimeter (DSC) (TA instruments). Lanosterol powder
was vacuum-oven-dried before taking it to the DSC. About 2 mg of lanosterol was put in
a closed DSC pan. An empty DSC pan was used as a blank. The samples were scanned
from 338.15 K to 433.15 K with a heating rate of 5.0 K/min. DSC experiments were done
in triplicate.

2.5. UV-VIS SPECTROSCOPY
Uv-vis spectra of lanosterol in methanol, the mobile phase in the HPLC
experiments, were acquired by a HITACHI U2900 Uv-vis spectrometer. The spectra
cover 190 nm to 1100nm and were acquired at room temperature.

2.6. SOLUBILITY DETERMINATION
Five or six mL of solvent and an excess amount of lanosterol were introduced
into the 25 mL glass flask described previously. The desired temperature was set and the
actual temperature in the glass vessel was recorded. Saturation was reached by adding
lanosterol to the solvent until it did not dissolve anymore. Different mixing and settle
down times were tested to determine a suitable equilibrium time. A combination of six
hours mixing time and 6 hours settle down time was enough to reach equilibrium in all
solvents. A sample of the upper clear portion of the mixture was withdrawn with a
preheated or precooled glass pipette, transferred to a 1 mL microcentrifuge tube, diluted
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100 times or to a proper concentration, and analyzed by HPLC. Each test was done in
triplicate.

2.7. HPLC ANALYSIS
The concentration of lanosterol was determined by HPLC. A Shimadzu LC-20AB
HPLC system with an Agilent ZORBAX SB-C18 column (2.1x50mm), CTO-10AS
column oven, SIL-20AS autosampler and SPD-M20A diode array detector was used.
Methanol was used as the mobile phase at a flow rate of 0.2 mL/min. The column oven
temperature was 30 oC, the injection volume was 5 pL, and the UV detector wavelength
was set at 215 nm.

3. DATA CORRELATION

The temperature dependence of the solubility was correlated by a modified
Apelblat equation (Eq.1), which is derived from the van’t Hoff isochore by assuming that
the apparent partial molar enthalpy of the solute is a linear function of temperature.[1416]
ln x = A +

B
+ C ln(T / K )
T/K

(1)

where x is molar solubility of lanosterol in the solvent; and A, B and C are fitting
parameters.
The solubility of a solid at constant pressure can be described by,[17]
ln(— )
r,x,

( -&

RTtJ { T

-1)

AC
R

(2)
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where Xi is the molar solubility of the solute,

y is the

activity coefficient of the solute i in

the liquid phase, R is the gas constant, AfmHt,i is the molar enthalpy of fusion of the solute
at the triple point temperature, Tt,t is the triple point temperature of the solute, and ACp,i is
the differential molar heat capacity of the pure solute. Two assumptions are usually
made[17-19] in Eq.2 that only introduce a slight error. The triple point and melting point
temperatures are usually close to each other. Therefore, the triple point temperature Tt,t
can be substituted by the melting temperature Tm,t. Moreover, the enthalpy of fusion at the
triple point temperature AfusHtj can be substituted by the enthalpy of fusion at the melting
point temperature AfUsHm,i. Second, the last two terms on the right-hand side of Eq.2 are
of opposite signs and of similar magnitude; therefore, they cancel each other. Then Eq.2
may be rewritten as,
ln(— )
r,x,

AfusH m,i /Tm,i i\
R T . (T
)

(3)

3.1. WILSON MODEL
The Wilson’s equation[20] provides a good representation of excess Gibbs
energies for a variety of miscible mixtures, particularly for solutions of polar components
in nonpolar solvents.[17] In a binary liquid-solid system, the activity coefficients are
given by,

l n r1

lnr 2

A 12

A 21

X1 + A 12 X2

X 2 + A 21X1

A 12

A 21

X1 + A 12 X 2

X 2 + A 21X1

l n ( x 1 + A 12X 2 ) + X 2 (

l n ( X 2 + A 21x 1 ) - X1 (

)

(4)

)

(5)
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RT
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^21 - ^ 2 2 \ _ V 1
) = 7 7 exp ( - ^
V
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where Aj are two adjustable parameters,

is the energy of interaction between molecules

i and j, and Vi is the molar volume of the component i .

3.2. NRTL MODEL
The nonrandom two-liquid equation was first introduced by Renon.[21] Unlike
the Wilson model, the NRTL model is applicable to partially miscible as well as
completely miscible systems. The activity coefficients a binary mixture are given by,
ln y = ==

ln Y 2 = =

*12 =

G 12

*21( '

^

g12 g22
RT

G„
-)2
X + x2G2l

* 1 2 ^ 12

+

(9)

~ --- )2+-

x 2 G xG ^

A§1:
RT

e x p (^12^12)

G 21

(8)

( x 2 + X 1G 1 2 >

( 1 + X2G 21)

g 21 - g11 _ Rg2
RT
RT

(10)

e x p ( ^ 1 2 p 21)

(11)

where Gj are adjustable parameters, Agj is the energy of interaction between molecules i
and j and a.12 is a nonrandom parameter which varies from 0.20 to 0.47.
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3.3. UNIQUAC MODEL
The UNIQUAC equation for excess Gibbs energy gE consist of two parts, a
combinatorial part and a residual part.23 The activity coefficients for a binary mixture are
given by,

, O z d1
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ln71 ln— + - qiln~ r +° 2(li li)
X1 2
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i+O2 T21) +02qC 21
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6

O 1=
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x q
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x i q + x 2^2
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x q
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x2r2
= ----- —
Xi7 + X2r2

(12)

@2 ^@1^12

, O 2 z , 62 , ,, r2
ln— + - ^ 2 l^ r + ° 2 (l2 - —li )
X2 2
O2
ri

ln72

1

12

@1

+ @2^21

(14)

(15)
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V
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V

RT
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:exp

:exp
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V T
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T
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(19)

where Tj are adjustable parameters, Auy are characteristic energies, the coordination
number z is set to be 10. The area parameters, q, and volume parameters, r, for lanosterol
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and the solvents were calculated according to references,[22-25] and summarized in
Table 2.

Table 2. UNIQUAC Parameters of Lanosterol and Solvents
Molecular weight
Compound

UNIQUAC
(g-mol-1)
q

r

Lanosterol

426.05

15.4570

19.1675

Methanol

32.04

1.4320

1.4311

Ethanol

46.07

2.5880

2.5755

Isopropanol

60.10

3.1240

3.2491

n-Propanol

60.10

3.1280

3.2499

Acetone

58.08

2.2960

2.5735

Acetonitrile

41.05

1.7240

1.8701

DMF

73.09

2.7360

3.0856

DMSO

78.13

2.4720

2.8266

Ethyl Acetate

88.11

3.1160

3.4786

A linear temperature dependence of the adjustable parameters of the three models
described above was assumed.[26] Therefore, Aj in the Wilson model, Tj in the NRTL
model and the Tj in the UNIQUAC model are given by Eq. 20 to 22.
Vi
A .. = —
j

V

exp

a..

b
TV

av + T / K

bj

\

(T / K ) J

(20)

(21)
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f
*a = exP a,.
V

b
\
(T / K )

(22)

where aj and bij are fitting parameters that are independent of composition and
temperature.

3.4. APELBLAT-JOUYBAN-ACREE MODEL AND VAN’T HOFF-JOUYBANACREE
The Apelblat -Jouyban-Acree model (Eq. 23) and van’t Hoff-Jouyban-Acree
model (Eq. 24) [27] are classic thermodynamic models which used to correlate the binary
system.
f . B2
A WW2 ^ w
v
B
ln x = w A +-----~ + C ln(T) + w,
A + T / k +C2ln(T)) + T t k l Jl ( W1~ w2^
3
1 1 T/K
1
(23)
B ^ ww
,
B
w1w2 2
i
ln x3 = Wj A +-------- + w. A2 +
1 T/K
T / K + O K l J ( w " w2>

(24)

where, xj is the mole fraction of lanosterol in binary mixture, wi and w 2 are water mass
fraction and alcohol mass fraction free of lanosterol. Ai, Bi Ci A 2, B 2, C2, Jo, Ji, and J 2 are
fitting parameters.

4. RESULTS AND DISCUSSION

Lanosterol purified by Pre-RP-HPLC has a purity of >95% by GC-MS.
Additionally, dihydrolanosterol, which is the major impurity in commercial lanosterol,
was obtained simultaneously. Lanosterol and dihydrolanosterol were identified using the
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standard mass spectra of National Institute of Standards and Technology (NIST) MS
spectral library and relevant references.[28] Ion groups at m/z of corresponding steroid
were monitored, lanosterol (69,109,393,411,426) and dihydrolanosterol
(43,69,395,413,428). The chromatogram and MS scan are shown in Figure S2 and S3.
The solubility of lanosterol in methanol, ethanol, isopropanol, w-propanol,
acetonitrile, acetone, DMF, DMSO, and ethyl acetate as a function of temperature is
summarized in Table 3 and is plotted in Figure 1. The solubility of lanosterol in
water-methanol, water-ethanol, and water-isopropanol mixtures is summarized in Table
4 and is plotted in Figures 2-4. The van’t Hoff plots of organic solvents and watermethanol, water-ethanol, and water-isopropanol mixtures are shown in Figures S4-S7.

Figure 1. The mole fraction of lanosterol X2 in selected solvents at different
temperatures. V, ethyl acetate; □ , acetone; ■ , ethanol; • , DMF; A, DMSO; O,
acetonitrile; ^ , methanol; +,isopropanol; x , w-propanol. The solid line are fittings of
data by the modified Apelblat equation
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Figure 2. The mole fraction of lanosterol (3) xj in water and water (l)-methanol (2)
mixture at different temperatures. • , water V2 =0 .0 0 ; X, V2=0.050; ^ , V2 =0 .2 0 ; + ,
V2=0.50; The insert shows the xj in □ , V2=0.70; O, V2=0.90 and ■ V2=1.00 ; —, the solid
line are fittings of data by the modified Apelblat equation

Figure 3. The mole fraction of lanosterol (3) xj in water and water (1)-ethanol (2) mixture
at different temperatures. □ , water V2=0.00; ■ , V2=0.050; • , V2=0.30; ^ , V2=0.60; the
insert shows the X, v2=0.90; O, v2=1.00, —, the solid line are fittings of data by the
modified Apelblat equation
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Figure 4. The mole fraction of lanosterol (3) xj in water and water (l)-isopropanol (2)
mixture at different temperatures.+ , water V2=0.00; □ , V2=0.050; ■ , V2=0.30; the insert
shows the O, V2=0.60; • , V2=0.90; X, v2=1.00; —, the solid line are fittings of data by
the modified Apelblat equation

Table 3. Mole fraction solubility X2 of lanosterol in organic solvents at temperature
range (277.09K-337.99K) under 101.8 KPaa
T/K

1000x2

Methanol (A)b

T/K

1000

Ethanol (D)b

x2

T/K

1000

Isopropanol (D)b

277.78

0.03

277.95

0.36

278.07

0.47

288.15

0.05

285.74

0.53

287.81

0.60

298.15

0.09

293.45

0.75

298.84

0.95

303.05

0.11

298.25

0.92

307.27

1.59

307.55

0.13

302.85

1.19

318.93

2.30

1.35
312.15

0.16

307.15

x2

57
Table 3. Mole fraction solubility X2 of lanosterol in organic solvents at temperature
range (277.09K-337.99K) under 101.8 KPaa (cont.)
T/K

1000x2

Methanol (A)b

T/K

1000

x2

T/K

1000

Isopropanol (D)b

Ethanol (D)b

316.95

0.21

312.35

1.68

321.65

0.32

318.05

2.14

w-propanol (D)b

Acetone (A)b

Acetonitrile (A)b

278.07

0.90

278.65

0.66

277.09

0.03

287.81

1.44

283.75

0.87

288.55

0.06

298.84

2.09

288.45

1.05

293.35

0.09

307.27

3.04

293.25

1.27

298.15

0.13

318.93

4.78

298.05

1.57

303.05

0.15

302.75

1.93

307.55

0.19

307.55

2.37

312.25

0.26

318.36

3.60

317.05

0.38

DMF (amorphous)b

DMSO (amorphous)b

Ethyl Acetate (A)b

277.15

0.35

293.95

0.15

277.67

0.76

284.65

0.51

297.65

0.19

288.55

1.27

289.15

0.63

302.35

0.24

293.25

1.65

294.65

0.73

307.15

0.31

298.05

1.87

297.35

0.89

312.95

0.42

302.85

2.35

300.15

1.03

318.69

0.57

307.45

2.84

303.05

1.38

337.99

1.36

318.64

4.43

308.46

1.87

x2
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Table 3. Mole fraction solubility X2 of lanosterol in organic solvents at temperature
range (277.09K-337.99K) under 101.8 KPaa (cont.)
T/K

1000

DMF (amorphous)b
318.55

T/K

x2

1000x2

DMSO (amorphous)b

T/K

1000x2

Ethyl Acetate (A)b

2.94

ax 2 is the experimental mole fraction solubility of lanosterol at temperature T; the
standard uncertainties u are u(T) = 0.01 K, u(P) = 0.22 kPa; the relative standard
uncertainty ur is ur(x2) = 0.023.
bLanosterol crystal forms in equilibrium with solvents.

Table 4. Mole fraction solubility xj of lanosterol (3) in water, water(1)-methanol(2),
water(1)-ethanol(2) and water(1)-isopropanol (2) binary mixtures at the temperature
range (278.15 K-338.78 K) under 101.8KPaa
T/K

W xs

water (1)- methanol(2) (A)b
water

V2=0.050,
W2=0.040

V2=0.20,
W2=0.16

V2=0.50,
W2=0.44

V2=0.70,
W2=0.65

V2=0.90,
W2=0.88

296.6
7

0.0032

0.0035

0.0037

0.0038

0.0648

13.0

306.8
1

0.0053

0.0059

0.0063

0.0079

0.116

29

316.9
4

0.0093

0.0133

0.0151

0.0206

0.223

54

328.9
7

0.0175

0.030

0.0370

0.047

0.47

111

338.7
8

0.028

0.067

0.073

0.101

1.15

water (1)- ethanol(2) (A)b

278.1
5

water

V2=0.050,
W2=0.040

V2=0.30,
W2=0.25

V2=0.60,
W2=0.54

V2=0.90,
W2=0.88

0.00141

0.0168

0.061

0.174

223
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Table 4. Mole fraction solubility xj of lanosterol (3) in water, water(1)-methanol(2),
water(1)-ethanol(2) and water(1)-isopropanol (2) binary mixtures at the temperature
range (278.15 K-338.78 K) under 101.8KPaa (cont.)
T/K

10x3
water (1)- ethanol(2) (A)b
water

V2=0.050,
W2=0.040

V2=0.30,
W2=0.25

V2=0.60,
W2=0.54

V2=0.90,
W2=0.88

288.1
5

0.00193

0.028

0.090

0.29

334

298.1
5

0.0042

0.046

0.141

0.44

468

308.1
5

0.0062

0.076

0.178

0.84

691

318.1
5

0.0123

0.114

0.221

1.20

769

water (1)- isopropanol(2) (A)b
water

V2=0.050,
W2=0.040

V2=0.30,
W2=0.25

V2=0.60,
W2=0.54

V2=0.90,
W2=0.88

278.1
5

0.00141

0.0088

0.080

10.70

162

288.1
5

0.00193

0.0122

0.090

14.2

300

298.1
5

0.0042

0.0139

0.113

20.8

412

308.1
5

0.0062

0.0171

0.123

25

522

318.1
5

0.0123

0.0223

0.130

31

708

ax 3 is the experimental mole fraction solubility of lanosterol at temperature T, V2 is volume
fraction of alcohols in water-alcohols binary system free of lanosterol, W2 is mass fraction
of alcohols in water-alcohols binary system free of lanosterol; the standard uncertainties u
are u(T) = 0.01 K, u(P) = 0.22 kPa; the relative standard uncertainty ur is ur(x3) = 0.043.
bLanosterol crystal forms in equilibrium with solvents.
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As shown in Figure 1, the solubility of lanosterol increases with increasing
temperature in all the solvents studied. From 277.78 K to 338.15 K, the solubility of
lanosterol is the largest in w-propanol and the lowest in methanol. The solubility of
lanosterol in DMF is lower than in ethanol below 300.15 K but it is higher above 300.15
K. Furthermore, below 298.15 K the lanosterol solubility in isopropanol is lower than in
the ethanol, above 298.15 K the order between isopropanol and ethanol switched. Around
277.15 K the lanosterol solubility increases according to the following order: methanol<
acetonitrile< DMF< isopropanol< acetone< ethanol< ethyl acetate< w-propanol and
around 318.15 K, the order change to: methanol< acetonitrile< DMSO< ethanol<
isopropanol< DMF< acetone< ethyl acetate< w-propanol.
The solvents were sorted into two groups according to their H-bond capacity. The
protic solvents group includes methanol, ethanol, w-propanol and isopropanol, and the
aprotic solvents group includes DMSO, DMF, acetone, acetonitrile and ethyl acetate. In
each group, the solubility of lanosterol increases with decreasing solvent polarity except
isopropanol. In addition, the solubility of lanosterol increases with decreasing Hanson
solubility parameters within each group except isopropanol in the protic solvents group,
except acetonitrile in aprotic solvents group. The Hanson solubility parameters,
polarity[29, 30] and polarizability[31] of solvents are summarized in Table S1.
Lanosterol has a highly hydrophobic steroid domain with a hydroxyl motif, which
makes the molecule weakly polar. The predominant intermolecular forces in the protic
solvents group are H-bond and dipole-dipole interactions. Polar protic solvents cannot
dissolve lanosterol efficiently because the weak H-bond between lanosterol and ethanol
or methanol cannot replace the strong H-bond in pure solvents without an energy penalty.
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Lanosterol is less soluble in methanol than in ethanol, isopropanol and w-propanol, which
is expected because methanol is a better H-bond molecule than other alcohols studied in
this work. The solubility of lanosterol increase while increasing alkyl chain length of
alcohols except isopropanol, maybe due to the hydroxyl group is in the middle of the
isopropanol alkyl chain. The solvents in the aprotic solvents group are only H-bond
acceptors. In such systems, the H-bond interactions are weaker than in the protic solvents
group. The dipole-dipole interaction in pure solvents become weaker as the polarity
decreases, then the weak dipole-dipole interaction between lanosterol and solvents may
easily replace the dipole-dipole interaction in pure solvents, causing higher solubility.
Dispersion forces or induced-dipole interactions may also contribute to dissolution.
Dispersion forces depend on the polarizability of solvents. In the aprotic solvents group,
the polarizabilities of each solvent are in the order of ethyl
acetate>DMSO>DMF>acetone>acetonitrile, but the solubilities of lanosterol do not
follow the order of polarizabilities except for ethyl acetate and acetonitrile. The above
observations lead to the conclusion that the lower the polarity of solvent the higher the
solubility of lanosterol, and that dispersion forces may also affect the solubility to some
degree in some solvents. To increase the solubility of lanosterol, n-hexane (polarity 0.9)
was tested. However, the solubility of lanosterol in w-hexane (data not shown) is even
lower than in ethyl acetate (polarity 23.0). Therefore, the dissolution of lanosterol is not
only affected by the polarity of solvent but by a synergy of dipole-dipole interactions, Hbond interactions and dispersion forces. This suggests that a low polarity solvent and a
weak H-bond capacity solvent mixtures may enhance the solubility of lanosterol. For
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example, it has been found that mixtures of ethanol and hexane increase the solubility of
cholesterol.[32]

The addition of alcohols to water increased lanosterol’s solubility. That indicates
that the alcohols are cosolvents of lanosterol in water. Lanosterol solubility increased
with increasing of temperature in water-alcohol mixtures and increased with increasing
alcohol content.
The PXRD pattern (Figure S8) of lanosterol before the solubility experiments
were conducted is identical to a previously reported pattern[33]. Ref 33 reported PXRD
for lanosterol powder and lanosterol crystallized in diisooctylphthalate (DIOP). In the
patent owned by Pan et al. [34] showed PXRD pattern of different lanosterol crystal
forms. According to this patent the crystal form of powder lanosterol is anhydrous Form
A. Figure S8 shows that the PXRD patterns changed after solubility experiments in
ethanol, isopropanol and w-propanol, which indicate that there is another polymorph
(Form D, according to the same patent) formed during the experiments. Furthermore, the
PXRD experiments show that the solid at equilibrium with solutions of lanosterol in
DMSO and DMF has lost the crystalline structure and forms amorphous precipitates. The
PXRD also shows that after vacuum-oven drying, the amorphous precipitate obtained
from precipitation in DMF and DMSO forms crystalline structures. In the other pure
solvents and in water-alcohol mixtures, the PXRD patterns are identical to the one
obtained with powder lanosterol. The crystal forms of lanosterol in equilibrium with
solvents were submitted in Table 3 and Table 4.
The melting temperature and enthalpy of fusion of the purified lanosterol were
determined to be 408.27 K with an uncertainty u(Tm) = 0.5 K and 23.61 kJ-mol-1 with an
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uncertainty u(AHfus ) = 0.14 kJ-mol"1, respectively. The molar extinction coefficient in
methanol at 202 nm was 382,801(M-cm)-1. Literature values of melting temperatures are
reported as the width of the endothermic peak, the onset of the endothermic peak or its
mean value. The melting temperature reported in this work is the onset temperature of
the endothermic peak because this value is less sensitive to heating rates and sample
mass. It is lower than the values reported by Boar et al.[8] (413.15 K), Maienthal and
Franklin[35] (411.15 K-413.15 K), Johnston and Bloch[9] (410.15 K-411.15 K) and
Jagodzinski and Rodewald[10] (419.15 K-420.15 K). The differences may be caused by
differences in purity, by the presence of different impurities because of the different
separation methods used and/or by the use of different experimental protocols. For
example, it has been found that the heating rate,[36] which is not reported in some of the
data, affects melting temperature measurements. [36] The DSC thermograph is shown in
Figure S9.
Figure S10 shows the DSC data for lanosterol solids obtained in solvents whose
PXRD patterns are different from the starting material’s one. The DSC results for
ethanol, isopropanol and w-propanol show two endothermic peaks. The peak around 370
K may be caused by eutectic process. The melting temperature and enthalpy of fusion of
lanosterol crystal formed in ethanol, isopropanol and w-propanol are 390.52 K with an
uncertainty u(Tm) = 0.5 K and 6.97 kJ-mol-1 with an uncertainty u(AHfUs) = 0.21kJ-mol-1,
respectively. The DSC results of the dried precipitates from DMSO and DMF both show
an endothermic peak around 386 K (Figure S10) which agree with PXRD patterns.
The solubility of lanosterol in organic solvents was correlated by the modified
Apelblat equation (Table 5), the Wilson, NRTL and UNIQUAC models (Table 6 except
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DMSO and DMF). The root mean square deviation (RMSD) of the experimental
solubility x"xp and calculated solubility x2"f were calculated as follow.
-|1/2

N

RMSD =

I

xcal —xexP
(25)

N

where N is the number of experimental data in each solvent at a given temperature.
In addition, in order to evaluate each model, the average absolute deviation
percentages (AADP) and relative average deviation (RAD) were calculated.
1
N
1

RAD = ■ vI
N ‘

„cal

x ;xp —x
v
I
N

x ;xp

100%

(26)

r 1x cal —xexp
vexp

(27)

The molar volume of lanosterol and the solvents were taken from Advanced
Chemistry Development ACD/Chemsketch Software (© 1994- 2018 ACD/Laboratories)
whereas the melting temperature (Tm,i) and enthalpy of fusion (AfUsH m, i) of lanosterol were
measured in this work.
Table 5 and Table 6 show that the correlated solubilities by all four models are in
good agreement with experimental data. The largest RMSD is 9.45*10-05 for the Wilson
model in w-propanol. The largest AADP is 8.26% for the NRTL model in isopropanol.
Assuming that ACp,t ~ 0 may have contributed to the deviation.[32]
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Table 5. Parameters of the Apelblat Equation and Root Mean Square Deviation
(RMSD) and the average absolute deviation percentage (AADP) for Lanosterol in
Selected Solvents
Solvents

A

B/T

C

105 RMSD

AADP
%

Methanol

-823.88

32557.15

123.77

0.92

9.05

Ethanol

-25.90

-2464.60

4.77

2.39

1.22

w-Propanol

-139.54

2899.70

21.70

4.33

2.72

Isopropanol

16.99

-4281.88

-1.67

7.66

8.07

Acetone

-40.66

-1686.88

6.99

1.60

1.13

Acetonitrile

-604.28

22145.50

91.42

0.80

7.42

DMF

88.49

-8649.48

-11.65

7.11

7.58

DMSO

39.58

-6431.80

-4.66

0.20

0.65

Ethyl Acetate -44.93

-1478.80

7.66

3.85

1.65

The solubility of lanosterol in binary water-alcohol mixtures was correlated by the
Apelblat-Jouyban-Acree and the van’t Hoff-Jouyban-Acree models. The RMSD, RAD
and fitted lanosterol mole fraction X3cal are shown in Table S2 and Figure S11-S13. The
van’t Hoff-Jouyban-Acree model fits the data better than the Apelblat-Jouyban-Acree
model. Most of the deviations are at the very low solubilities observed at very low
organic solvent mole fractions.
The parameters bij/T in the Wilson model are negligible when compared to aij
A X ,

(Table 6) which are approximately equal to the

RT

terms in Eq. 6 and 7. The AXj in

Wilson model of the lanosterol-methanol system are AX12 =-2932.32 and AX21 =13749.52
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which are of the same order of magnitude of a similar steroid molecule, desmosterol in
methanol (AA12 =-3827.52 and AA 21 =14298.65).

Table 6. Interaction Parameters and Root Mean Square Deviation (RMSD) and the
Average Absolute Deviation Percentage (AADP) for Wilson, NRTL and UNIQUAC
Models
Wilson
Solvent
ai2

bn/K

a2i

b2i/K

105RMSD

AADP%

Methanol

2.88

-6.74

-10.37

5.73

0.63

4.61

Ethanol

1.31

0.091

-9.30

4.44

5.15

2.84

Isopropanol 0.97

-0.24

-8.77

4.13

3.97

1.84

w-Propanol

1.00

0.46

-8.09

3.41

9.45

3.04

Acetone

2.07

-2.57

-6.29

3.85

4.97

2.07

Acetonitrile 2.76

-11.40

-10.15

5.15

1.28

6.32

Ethyl
Acetate

-0.93

-5.85

-0.28

7.83

2.81

ai2

bi2/K

a2i

b2i/K

105RMSD

AADP%

Methanol

-4.62

-44.01

3.28

396.66

1.97

5.37

Ethanol

-2.11

-1128.88

2.01

813.17

2.70

1.91

130.31

2.39

575.61

8.62

8.26

1.82
NRTLa

Solvent

Isopropanol -4.42
n-Propanol

-10.31

2476.33

3.57

23.18

5.74

2.03

Acetone

-3.00

43.04

2.62

235.76

1.65

1.05

Acetonitrile -1.78

2456.85

-336.24

-364.61

1.36

4.55

Ethyl
Acetate

-89.38

1.26

295.20

3.77

1.40

-1.52
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Table 6. Interaction Parameters and Root Mean Square Deviation (RMSD) and the
Average Absolute Deviation Percentage (AADP) for Wilson, NRTL and UNIQUAC
Models (cont.)
UNIQUAC
Solvent
a i2

b i2 / K

a2i

b2i/K

105 R M

Methanol

-1.76

-125.06

0.71

25.41

0.52

3.46

Ethanol

0.83

-200.20

-1.41

40.28

1.81

1.27

Isopropanol

-1.18

-130.38

0.42

29.89

7.56

3.98

n-Propanol

0.19

-150.04

-0.86

10.89

3.79

1.87

Acetone

0.23

-49.08

-0.90

6.49

1.45

1.01

Acetonitrile

-1.49

-63.40

0.74

-33.07

0.66

3.56

Ethyl
Acetate

0.44

-52.48

-1.05

-5.14

3.76

1.38

a The nonrandom parameter in the NRTL model is

a =

SD

A A D P %

0.2

Furthermore, a2 i increases with decreasing solvent polarity within each solvent
groups. This indicates that with decreasing solvent polarity, the interaction energy
difference between the solvent and lanosterol and between the pure solvents ( AXij)
becomes smaller. Then it leads to activity coefficients approximately equal to one. If the
activity coefficients are closer to one, the interactions between solute and solvent are
similar to solvent-solvent interactions. Therefore, replacement of solvent-solvent bonds
by solvent-solute bonds is favorable and the solubility increases. This dependence of the
coefficients of Wison model with solvent polarity was not found in the other two models.
The interaction parameters, Ag i 2 =gi 2 -gi i , Ag2 i =g2 i -g22 and Au i 2 = ui 2 - ui i ,

Au2 i = u2 i - u2 2 for the NRTL and UNIQUAC models are presented in Table S3. The g u and
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uu are the energy of evaporation of lanosterol in each solvent. The %■ and gj are the
interaction energies between lanosterol and solvents such as gi 2=g2i, ui2=u2i. In the
NRTL model, the Agn are positive for all solvents, which indicates that the interaction
energy between solvent and solute are larger than the evaporation energy of the solvents.
Ag2i are negative in all solvents. Aui2 in the UNIQUAC model are all positive whereas
the Au2 i are negative for all solvents. Although the Auj and Agj in both models are related
to the evaporation energy of solute and solvents, the values show a large difference. The
discrepancy between the two models is likely to be caused by the absence of an entropic
term in the NRTL model.[37, 38]
The mixing properties, AmixG, AmixS and AmixH were computed using the Wilson
Equation and summarized in Table S4. The mixing enthalpies (AmixH) in all solvents are
positive except for acetonitrile and ethyl acetate, therefore, the dissolution of lanosterol is
an endothermic process. Only for acetonitrile and ethyl acetate, the dissolution is
exothermic. The mixing entropies (AmixS) are positive for all solvents, which indicates all
solvent-lanosterol systems become more disorder and the dissolution is an entropy-driven
process. The mixing Gibbs energy (AmixG) of all solvents are negative and decrease with
increasing temperature. The dissolution of lanosterol in all selected solvents is
spontaneous.
In the absence of binary interaction parameters, the solubility of lanosterol in
methanol-water systems at 298.15 K were predicted by the modified Wilson model
1
sat 1 W (1 + ln xSat) w (1 + ln xSat)
- ln xSat = 1----^
^
----^
^
W1+ W2^2
V 21 + W2

. .
(28)
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where x ^ 1is the solubility of the solute in the mixed solvents xSat and x s^ aare the solute
solubility in organic solvent and water at a given temperature; Wi and W2 are the mass
fractions of organic solvent and water; and
Replacing the

are the energy of interaction parameters.

with Abraham solute parameters in Eq. 28 we obtain,

W (1 + ln xSat)
- ln x?at = 1—
W\ +W (J + J E +J 2S +J y A +J

+J V )

S

(29)

W2 (1 + ln x )
W (J '0+ J \ E + J \ S +J \ A + J \ B + J \ V) + w2
where Ji and Ji terms are model constants; E, S, A, B, V are Abraham solute parameters,
which are the excess molar refraction (E), the dipolarity/polarizability of the solute (S),
the solute's hydrogen-bond acidity and basicity(A, B) and the McGowan volume of the
solute(V). Barzegar-Jalali et al. [39] suggested a set of J and J ’that were regressed from
41 drug solubility data sets for methanol-water systems. The trained version of the
modified Wilson model for methanol-water systems is,
W (1 + ln xfat)
- ln x.Sat = 1—
W + w2(0.626 - 0.622E + 0.339S + 0.246A + 0.218B - 0.096V)

(30)

____________________ w2(1 + ln x2Sat)___________________
W (1.525 + 0.108E - 0.109S + 0.092A + 0.586B - 0.228V) + w2
The Abraham solute parameters of lanosterol were calculated by ACD/I-Lab
software: E = 1.41, S = 1.67, A = 0.31, B = 0.9, V =3.8739.
The solubility of lanosterol in methanol-water mixtures was measured and
compared with the solubility predicted by Eq. 30 (Figure 5). The molar solubility of
lanosterol in water is 3.2 x10-9. Interestingly, the modified Wilson model predicted that
the lanosterol’s solubility first decreases and then increases with increasing methanol
volume fraction.
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Figure 5. The solubility of lanosterol (X3 ) in water (l)-methanol (2) binary mixtures
compare with the solubility predicted by modified Wilson model.■ , 296.67 K; • , 306.81
K; A, 316.94 K; V, 328.97 K; □ , 338.78 K. The solid line represents solubility
prediction by the modified Wilson model. The inset shows natural logarithmic solubility

The solubilities predicted by Eq. 30 deviate less from the experimental data at low
and high methanol volume fraction. The overall relative deviation is 344 %. The modified
Wilson model may only applicable at high methanol content for lanosterol.
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5. CONCLUSIONS

The solubility of lanosterol in nine organic solvents from 277.09 K to 338.15 K
and in water-alcohol mixtures from 277.78 K to 338.78 K was measured. The melting
temperature and enthalpy of fusion of lanosterol were determined to be 408.27 K and
23.61 kJ-mol-1, respectively. The solubility of lanosterol in n-propanol is the largest one
among the selected solvents. The activity coefficient models of Wilson, NRTL and
UNIQUAC correlated the experimental data satisfactorily. The Apelblat -Jouyban-Acree
and the van’t Hoff-Jouyban-Acree models correlated water-alcohol binary systems
without significant deviations.
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APPENDIX

SUPPORTING INFORMATION OF II. SOLUBILITY OF LANOSTEROL IN
ORGANIC SOLVENTS AND IN WATER-ALCOHOL MIXTURES AT 101.8 KPA

Table S1. The solubility parameter, polarity and polarizability of solvents
Solvent

Solubility
Parameter^
(J-cm"3)0'5

Polaritya (Water 100)

Polarizability
(A3)

Methanol

29.52

76.2

3.26

Ethanol

26.58

65.4

5 13

Isopropanol

23.8

54.6

7 14

w-propanol

24.5

61.7

7 23

Acetone

20.05

35.5

6 47

Acetonitrile

24.09

46

4 44

DMF

23.97

40.4

7 93

DMSO

26.33

44.4

8 03

Ethyl Acetate

18.35

23

8 87

n-Hexane

14.9

0.9

11.94

a Taken from Reference 1 and 2.
b Taken from Reference 3'
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Table S2. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (R AD )
for the solubility of lanosterol (xj) in water-methanol binary mixturesa

water(1 )-methanol (2)
van’t
HoffJouyban
-Acree

T/K

W2

X3exp

v cal-apb
X3

v cal-van
X3

ApelblatJouybanAcree

296.67

0.00

3.25E-09

2.27E-09

5.44E-10 Ai

-497.83

Ai

10.81

306.81

0.00

5.30E-09

2.51E-09

1.57E-09 Bi

20730.00

Bi

-9537.74

316.94

0.00

9.33E-09

2.97E-09

4.25E-09

A2

9.36

328.97

0.00

1.75E-08

3.92E-09

1.28E-08 A 2

-823.63

B2

-5620.29

338.78

0.00

2.81E-08

5.19E-09

2.96E-08

B2

32600.00

Jo

-5277.64

296.67

0.040

3.53E-09

3.55E-09

1.14E-09

C2

123.70

Ji

126.75

306.81

0.040

5.95E-09

3.99E-09

3.22E-09 Jo

-4922.56

J2

8573.20

316.94

0.040

1.33E-08

4.80E-09

8.47E-09 Ji

-685.88

328.97

0.040

3.02E-08

6.48E-09

2.48E-08

6864.09

338.78

0.040

6.56E-08

8.74E-09

5.62E-08

296.67

0.16

3.66E-09

4.37E-09

2.04E-09

306.81

0.16

6.34E-09

5.34E-09

5.62E-09

316.94

0.16

1.51E-08

7.01E-09

1.45E-08

328.97

0.16

3.70E-08

1.05E-08

4.12E-08

338.78

0.16

7.33E-08

1.54E-08

9.16E-08

296.67

0.44

3.83E-09

3.69E-09

1.34E-09

306.81

0.44

7.91E-09

5.62E-09

3.68E-09

316.94

0.44

2.06E-08

9.21E-09

9.48E-09

Ci 71.67

J2
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Table S2. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (R AD )
for the solubility of lanosterol (xj) in water-methanol binary mixtures (cont.)
water(1 )-methanol (2)

v cal-apb

v cal-van

T /K

W2

X3exp

x3

x3

328.97

0.44

4.72E-08

1.80E-08

2.70E-08

338.78

0.44

1.01E-07

3.27E-08

6.01E-08

296.67

0.65

6.49E-08

8.24E-08

3.46E-08

306.81

0.65

1.01E-07

1.33E-07

8.45E-08

316.94

0.65

1.98E-07

2.33E-07

1.95E-07

328.97

0.65

4.74E-07

4.97E-07

4.92E-07

338.78

0.65

1.00E-06

9.79E-07

9.98E-07

296.67

0.88

1.30E-05

1.77E-05

1.45E-05

306.81

0.88

2.94E-05

2.86E-05

2.87E-05

316.94

0.88

5.47E-05

5.08E-05

5.43E-05

328.97

0.88

0.00011

0.000111

0.00011

277.78

1.00

2.70E-05

3.69E-05

1.9E-05

288.15

1.00

4.86E-05

5.03E-05

3.93E-05

298.15

1.00

8.83E-05

7.7E-05

7.56E-05

303.05

1.00

0.00011

9.87E-05

0.000103

307.55

1.00

0.00013

0.00013

0.00013

312.15

1.00

0.00016

0.00017

0.00018

316.95

1.00

0.00021

0.00023

0.00023

321.65

1.00

0.00032

0.00031

0.00030

ApelblatJouybanAcree

van’t
H offJouyban
-Acree
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Table S2. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (R AD )
for the solubility of lanosterol (xj) in water-methanol binary mixtures (cont.)

water(1 )-methanol (2)

T/K

W2

X3exP

xj cal-apb

van’t
HoffJouyban
-Acree

ApelblatJouybanAcree

v cal-van
x3

Apelblat- RAD
0.39
JouybanAcree
RMSD 1.88E-06
van’t
HoffJouybanAcree

RAD

0.21

RMSD 2.59E-06

a W2 is mass fraction of alcohols in a water-alcohol binary system free of lanosterol; x / al"
apb and x / al"van are calculated lanosterol mole fractions by the Apelblat-Jouyban-Acree and
van’t Hoff-Jouyban-Acree models respectively.

Table S3. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (RAD)
for the solubility of lanosterol (xj) in water-ethanol binary mixtures.a
water(1 )-ethanol(2)

T

/K

W2

x 3 exP

x3

cal-apb

van’t
HoffJouybanAcree

ApelblatJouybanAcree

x3cal-van

278.15

0.00

1.43E-09 4.37E-09

9E-09

Ai

-507.613

Ai

-9.35289

288.15

0.00

1.94E-09

6.33E-09

1.22E-08 Bi

19136.32

Bi

-2721.48

298.15

0.00

4.17E-09

9.68E-09

1.62E-08

Ci

74.45794

A2

2.54205
2

308.15

0.00

6.21E-09

1.70E-08

2.22E-08 A2

-727.768

B2

-2785.93
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Table S3. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (R AD )
for the solubility of lanosterol (xj) in water-ethanol binary mixtures (cont.)
water(1 )-ethanol(2)

v cal-apb

van’t
H offJouybanAcree

ApelblatJouybanAcree

v cal-van

T /K

W2

X 3 exp

X3

X3

318.15

0.00

1.25E-08

2.82E-08

2.81E-08

B2

30018.84

Jo

-1969.19

278.15

0.040

1.73E-08

1.28E-08

1.19E-08

C2

108.8534

Jl

-14.3242

288.15

0.040

2.79E-08

1.56E-08

1.65E-08

Jo

-2745.25

J2

5998.03

298.15

0.040

4.57E-08

2.05E-08

2.24E-08

Jl

1714.521

308.15

0.040

7.64E-08

2.88E-08

2.97E-08

J2

10612.25

318.15

0.040

1.06E-07

4.27E-08

3.88E-08

278.15

0.25

6.07E-08

1.01E-07

6.54E-08

288.15

0.25

8.96E-08

1.22E-07

9.31E-08

298.15

0.25

1.35E-07

1.61E-07

1.29E-07

308.15

0.25

1.80E-07

2.27E-07

1.76E-07

318.15

0.25

2.25E-07

3.42E-07

2.35E-07

278.15

0.54

1.73E-07

1.93E-07

4.74E-07

288.15

0.54

2.87E-07

2.48E-07

7.10E-07

298.15

0.54

4.42E-07

3.50E-07

1.03E-06

308.15

0.54

8.38E-07

5.34E-07

1.47E-06

318.15

0.54

1.20E-06

8.72E-07

2.05E-06

278.15

0.88

0.00022

0.00034

0.00025

288.15

0.88

0.00033

0.00038

0.00034

298.15

0.88

0.00047

0.00046

0.00047

308.15

0.88

0.00069

0.00063

0.00062

318.15

0.88

0.00077

0.00093

0.00081
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Table S3. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (R AD )
for the solubility of lanosterol (xj) in water-ethanol binary mixtures (cont.)

water(1 )-ethanol(2)

v cal-apb

v cal-van

T /K

W2

X 3 exp

X3

X3

318.05

1.00

0.0021

0.0021

0.0020

312.35

1.00

0.0017

0.0017

0.0017

307.15

1.00

0.0014

0.0014

0.0015

302.85

1.00

0.0012

0.0012

0.0013

298.25

1.00

0.0010

0.0010

0.0011

293.45

1.00

0.00092

0.00091

0.0010

285.74

1.00

0.00082

0.00080

0.00074

277.95

1.00

0.00073

0.00075

0.00056

Apelblat

R A D

0.32

JouybanAcree
van’t
HoffJouybanAcree

ApelblatJouybanAcree

van’t
HoffJouybanAcree

R M S
D

2.88E-05

R A D

0.38

R M S
D

3.98E-05

a W2 is mass fraction of alcohols in a water-alcohol binary system free of lanosterol; x / al"
apb and x / al"van are calculated lanosterol mole fractions by the Apelblat-Jouyban-Acree and
van’t Hoff-Jouyban-Acree models respectively.
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Table S4. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (R AD )
for the solubility of lanosterol (xj) in water-isopropanol binary mixtures
water(1)-isopropanol (2)

T/ K

W2

X3exp

v cal-apb
X3

v cal-van

X3

ApelblatJouybanAcree

van’t
H offJouybanAcree

278.15

0.00

1.43E-09

4.37E-09

8.43E-13

Ai

-507.61

Ai

5.75931
4

288.15

0.00

1.94E-09

6.33E-09

8.75E-13

Bi

19136.32

Bi

-3771.12

298.15

0.00

4.17E-09

9.68E-09

9.06E-13

Ci

74.45

A2

-26.6873

308.15

0.00

6.21E-09

1.70E-08

9.41E-13

A2

16.99

B2

-330.517

318.15

0.00

1.25E-08

2.82E-08

9.69E-13

B2

-4281.89

Jo

7328.28
1

278.15

0.040

8.79E-09

3.68E-09

1.55E-11

C2

-1.67

Ji

-6306.84

288.15

0.040

1.23E-08

4.75E-09

1.53E-11

Jo

1632.95

J2

3343.80
4

298.15

0.040

1.41E-08

6.56E-09

1.5E-11

Ji

-1464.48

308.15

0.040

1.69E-08

9.59E-09

1.48E-11

J2

-1554.38

318.15

0.040

2.21E-08

1.47E-08

1.46E-11

278.15

0.25

7.97E-08

7.64E-08

2.57E-07

288.15

0.25

9.02E-08

1.02E-07

2.29E-07

298.15

0.25

1.07E-07

1.42E-07

2.06E-07

308.15

0.25

1.19E-07

2.06E-07

1.86E-07

318.15

0.25

1.31E-07

3.10E-07

1.69E-07

278.15

0.54

1.07E-05

8.03E-06

1.82E-05

288.15

0.54

1.41E-05

1.10E-05

1.94E-05
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Table S4. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (R AD )
for the solubility of lanosterol (xj) in water-isopropanol binary mixtures (cont.)

water(1)-isopropanol(2)

v cal-apb

v cal-van

T /K

W2

X 3 exp

X3

X3

298.15

0.54

2.08E-05

1.53E-05

2.05E-05

308.15

0.54

2.51E-05

2.17E-05

2.17E-05

318.15

0.54

3.10E-05

3.10E-05

2.28E-05

278.15

0.88

0.00016

0.00019

0.00020

288.15

0.88

0.00030

0.00029

0.00028

298.15

0.88

0.00041

0.00044

0.00039

308.15

0.88

0.00052

0.00064

0.00053

318.15

0.88

0.00071

0.00093

0.00071

278.07

1.00

0.00047

0.00041

0.00041

287.81

1.00

0.00060

0.00065

0.0006

298.84

1.00

0.00095

0.00105

0.0010

307.27

1.00

0.0016

0.0015

0.0015

318.93

1.00

0.0023

0.0023

0.0023

Apelblat

R A D

0.36

JouybanAcree
van’t
HoffJouybanAcree

ApelblatJouybanAcree

van’t
HoffJouybanAcree

R M S
D

0.00037

R A D

0.23

R M S
D

6.51E-06

a W2 is mass fraction of alcohols in a water-alcohol binary system free of lanosterol; x / al"
apb and x / al"van are calculated lanosterol mole fractions by the Apelblat-Jouyban-Acree and
van’t Hoff-Jouyban-Acree models respectively.

84

Table S5. Interaction Parameters for the NRTL and UNIQUAC Models
NRTL
Solvent
A g12

A g2i

a

Methanol

3786.04

-1893.02

0.20

Ethanol

5866.49

-2933.24

0.20

Isopropanol

5929.32

-2964.66

0.20

w-Propanol

5389.93

-2694.96

0.20

Acetone

4027.24

-2013.62

0.20

Acetonitrile

6080.32

-3040.16

0.20

Ethyl Acetate

3866.78

-1933.39

0.20

UNIQUAC
Solvent
A u i2

Au21

Methanol

162.67

-81.34

Ethanol

90.00

-45.00

Isopropanol

153.36

-76.68

w-Propanol

147.01

-73.51

Acetone

83.04

-41.53

Acetonitrile

136.14

-68.07

Ethyl Acetate

62.43

-31.22
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Table S6. The Calculated Values for AGmtx Gibbs Free Energy of Mixing,
AHmtx Enthalpy of Mixing and ASmtx Entropy of Mixing
AGmix

AHmix

ASmix

J-mol-1

J-mol-1

J-mol-1

277.78

-1.19

0.00040

0.0043

288.15

-2.16

0.00072

0.0070

298.15

-3.93

0.0013

0.013

303.05

-4.82

0.0016

0.016

307.55

-5.70

0.0019

0.019

312.15

-7.11

0.0024

0.023

316.95

-9.54

0.0032

0.030

321.65

-14.28

0.0048

0.044

277.95

-14.16

0.013

0.051

285.74

-21.25

0.020

0.074

293.45

-30.10

0.028

0.10

298.25

-37.17

0.035

0.12

302.85

-47.83

0.045

0.15

307.15

-54.82

0.051

0.17

312.35

-68.29

0.064

0.21

318.05

-87.13

0.082

0.27

278.07

-18.45

0.014

0.066

287.81

-23.84

0.018

0.083

298.84

-38.05

0.029

0.13

307.27

-63.57

0.048

0.21

T/K
Methanol

Ethanol

Isopropanol
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Table S6. The Calculated Values for AGmtx Gibbs Free Energy of Mixing,
AHmtx Enthalpy of Mixing and ASmtx Entropy of Mixing (cont.)
AGmix

AHmix

ASmix

J-mol-1

J-mol-1

J^mol-1

-92.89

0.069

0.29

278.07

-32.16

0.033

0.12

287.81

-51.60

0.052

0.18

298.84

-75.64

0.076

0.25

307.27

-110.31

0.11

0.36

318.93

-174.39

0.17

0.55

278.65

-19.19

0.015

0.070

283.75

-25.20

0.020

0.090

288.45

-30.50

0.024

0.11

293.25

-36.92

0.029

0.13

298.05

-45.56

0.036

0.15

302.75

-55.89

0.044

0.18

307.55

-68.47

0.054

0.22

318.36

-103.74

0.082

0.33

277.09

-1.38

-0.00021

0.0050

288.55

-2.80

-0.00041

0.010

293.35

-4.10

-0.00060

0.014

298.15

-5.45

-0.00080

0.018

303.05

-6.75

-0.0010

0.022

T/K
318.93
w-propanol

Acetone

Acetonitrile
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Table S6. The Calculated Values for AGmtx Gibbs Free Energy of Mixing,
AHmtx Enthalpy of Mixing and ASmtx Entropy of Mixing (cont.)
AGmix

AHmix

ASmix

J-mol-1

J-mol-1

J-mol-1

307.55

-8.48

-0.0012

0.028

312.25

-11.33

-0.0016

0.036

317.05

-16.49

-0.0024

0.052

277.67

-21.42

-0.0060

0.077

288.55

-35.80

-0.010

0.12

293.25

-46.22

-0.013

0.16

298.05

-52.65

-0.015

0.18

302.85

-65.88

-0.019

0.22

307.45

-79.45

-0.022

0.26

318.64

-123.16

-0.035

0.39

T/K

Ethyl Acetate
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Table S7. Solubility of lanosterol (3) in water (l)-methanol (2) binary mixture
predicted by the Modified Wilson compare with experimental data
296.67 K

W2

Xexp^ xpre3

0.0
4

3.5
3E09

1.92
E09

RD
%
45.5
5

XeXp3
5.95
E09

306.81 K

Xpre3
3.69
E09

37.8
9

RD%
1.33
E08

6.34
E-09

316.94 K

XeXp3

Xpre3

RD
%

52.
17

0.16

3.66E
-09

1.58E
-09

56.76

6.34E
-09

3.28E
-09

48.17

1.51E
-08

6.34E
-09

0.58

0.44

3.83E
-09

2.82E
-08

636.1
5

7.91E
-09

5.84E
-08

638.0
5

2.06E
-08

1.21E
-07

4.90

0.65

6.49E
-08

4.95E
-07

662.0
8

1.01E
-07

9.62E
-07

851.7
7

1.98E
-07

1.95E
-06

8.88

0.88

1.30E
-05

1.30E
-05

0.34

2.94E
-05

2.32E
-05

21.07

5.47E
-05

4.48E
-05

0.18

328.97 K

338.78 K

W2

Xexp3

Xpre3

RD%

Xexp3

Xpre3

RD%

0.04

3.02E
-08

1.33E
-08

56.08

6.56E
-08

2.36E
-08

64.03

0.16

3.70E
-08

1.55E
-08

57.98

7.33E
-08

3.22E
-08

56.11

0.44

4.72E
-08

3.30E
-07

599.7
4

1.01E
-07

7.73E
-07

665.9
5

0.65

4.74E
-07

5.13E
-06

982.5
9

1.00E
-06

1.19E
-05

1084.
95

0.88

0.000
11

0.000
11

1.16
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Figure S1. Schematic diagram of the experimental set up: I, water circulating bath; II,
condenser; III, thermocouple; IV, magnetic stirrers; V, magnetic stirrer controller; VI,
water jacketed three necks glass vessel; VII, sampling port
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% Intensity

Figure S2. Total ions chromatogram of purified lanosterol in methanol by GC-MS. The
retention time of lanosterol is 25.62 minutes and the purity o f lanosterol is >95%

m/z

Figure S3. MS scan of lanosterol in methanol at 25.62 minutes. Ion groups (m/z) are
found as 69,109,393,411 and 426 which indicate by a red circle, respectively. MS scan
results were compared with data from reference 4 to confirm that the sample is lanosterol
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Figure S4. van’t Hoff plots of ln(x2 ) versus 1/T in different solvent. T,methanol;
0,acetonitrile;A, DMSO; • , DMF; ■ , ethanol; □ , acetone; V, ethyl acetate; ▲,
isopropanol; and x , ^-propanol. The solid lines are the solubilities fitted by the modified
Apelblat equation

Figure S5. van’t Hoff plots of ln(xj) versus 1/T in water (1)-methanol (2) mixtures. ♦ ,
water; ▲, V2=0.050; ▼, V2=0.20; • , V2=0.50; □ , V2=0.70;and O, V2=0.90. The solid lines
are the solubilities fitted by the modified Apelblat equation
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Figure S6. van’t Hoff plots of ln(xj) versus 1/T in water (l)-ethanol (2) mixtures. ♦ ,
water; ■ , V2=0.050; O, V2=0.30; • , V2=0.60; □ , V2=0.90. The solid lines are the
solubilities fitted by the modified Apelblat equation

Figure S7. van’t Hoff plots of ln(xj) versus 1/T in water (l)-isopropanol (2) mixtures. ♦ ,
water; □ V2=0.050; • , V2=0.30; O, V2=0.60;^, V2=0.90. The solid lines are the
solubilities fitted by the modified Apelblat equation

93

\
'

c

V.

.

(s )

(f)

S'
«
S

■\

(0

20000 - \

(e)

■J
\

/

„

l

(a)

10

2 B/degree

Figure S8. X-ray diffraction patterns from 2° to 20° 29/ degree of lanosterol powder and
lanosterol precipitates at equilibrium with lanosterol solutions in pure solvents and wateralchol mixtures. A) (a) powder lanosterol before solubility experiments; (b) ethanol; (c)
isopropanol; (d) w-propanol; (e) DMSO; (f) DMF; (g) actonitrile; (h) methanol; (i)
acetone; (j) ethyl acetate; (k) water; B) (l) 5%(v/v) ethanol; (m) 90% ethanol; (n) 5%
methanol; (o) 90% methanol; (p) 5% isopropanol; (q) 90% isopropanol; C) lanosterol
precipitates at equilibrium with solutions of lanosterol in DMSO and DMF vacuum-oven
dried 24 hours; (a) lanosterol powder before solubility experiments; (e) wet lanosterol at
equilibrium with a lanosterol solution in DMSO; (r) dried lanosterol at equilibrium with a
lanosterol solution in DMSO; (s), dried lanosterol at equilibrium with a lanosterol
solution in DMF
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Figure S9. Differential scanning calorimetry (DSC) of lanosterol from 338.15 K-433.15
K. The onset Tm is 408.27 K with an uncertainty u(Tm) = 0.50 K; the peak of Tm is 412.39
K with an uncertainty u(Tm) = 0.60 K; the enthalpy of fusion AHfUs of lanosterol is 23.61
kJ with an uncertainty u (AH/us ) = 0.13kJ-mol-1. DSC experiments were done in triplicate

Figure S10. Differential scanning calorimetry (DSC) of lanosterol after solubility
measurements. A), dried precipitate at equilibrium with a lanosterol solution in DMSO
and DMF; B), dried precipitate at equilibrium with a lanosterol solution in ethanol,
isopropanol and w-propanol
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Figure S11. The mole fraction of lanosterol (3), X3 , in water and water (l)-methanol (2)
mixture as a function of temperature. □ , V2=0.70; O, V2=0.90; A, V2=1.00. The insert
shows X3 in • , water V2=0.00; ■ , V2=0.050; ▲, V2=0.20; ▼, V2=0.50; The solid lines are
the solubilities fitted by the Apelblat-Jouyban-Acree model and the dash lines are the
solubilities fitted by van’t Hoff-Jouyban-Acree model
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Figure S12. The mole fraction of lanosterol (3) xj in water and water (l)-ethanol (2)
mixture as a function of temperature. ▲, V2=0.60; A, V2=0.90; ▼, V2 = 1.00. The insert
shows x3 in :►, water; ■ , V2=0.050; and • , V2=0.30. The solid lines are the solubilities
fitted by the Apelblat-Jouyban-Acree model and the dash lines are the solubilities fitted
by van’t Hoff-Jouyban-Acree model

Figure S13. The mole fraction of lanosterol (3) xj in water and water (1)-isopropanol (2)
mixtures as a function of temperature. ■ , V2=0.30; O, V2=0.60; • , V2=0.90; and ▼, V2=
1.00. The insert shows x 3 in ►, water; and □ , V2=0.050. The solid lines are the
solubilities fitted by the Apelblat-Jouyban-Acree model and the dash lines are the
solubilities fitted by van’t Hoff-Jouyban-Acree model
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III. IS IT POSSIBLE TO PREVENT AGGREGATION OF ALPHA CRYSTALLIN
BY ADDING STEROLS?

ABSTRACT

Cataract is the main cause of blindness in the world. By age 75, half of the
Americans will have cataracts according to the National Eye Institute. The only available
treatment consists of replacing the damaged lenses by artificial ones. Although the
surgery is safe and it corrects vision problems, not every patient has easy to access to the
surgery especially in developing countries. In 2015 two reports were published claiming
that lanosterol (LAN) and 25-hydroxycholesterol (25HD) restored lens’ clarity. Since
then, there is almost an equal number of publications reporting restoration of lenses
clarity by lanosterol and 25-hydroxycholesterol as those refuting those findings. There is
a broader question to be asked: are sterols able to prevent protein aggregation in general?
Previous studies were all focused on restoring the lenses’ transparency but the effects of
the two sterols on the a-crystallin aggregation process has not been investigated. In this
study we showed these two sterols fail to prevent a-crystallin heat induced aggregation.
Furthermore, sterols at high concentration actually promote a-crystallin aggregation but
the a-crystallin chaperone activity seems to remain intact. FTIR and CD spectra show
that the secondary and tertiary structures of a-crystallin does not change significantly in
the present of the two sterols. Cu2+ binding experiments and bis-ANS hydrophobic
fluorescent assay further indicate that there is no interactions between a-crystallin and
those two sterols. Our results show no evidence to support specific interactions between

99
a-crystallin and those two sterols and that the lost in chaperone activity is caused by
aggregation of a-crystallin.

1. INTRODUCTION

Cataracts are the main cause of blindness in the world. By age 75, half of the
Americans have cataracts according to the National Eye Institute.[1] The only available
treatment presented by previous literature was replacing the damaged lenses by artificial
ones. Although the surgery is safe and it corrects vision problems, not every patient,
especially in developing countries, has easy to access to the procedure.[2]
The lens has an onion-like layered structures. Outward facing lens edges have
mono-layer of epithelial cells that differentiate to new fiber cells during lens development
over the lifetime of a individual[2]. To maintain lens transparency, fiber cells lack of
blood vessels and the sub-cellular structures of the fiber cells were removed during
differentiation^]. Lenses’ high refractive indexes are caused by the high concentration
of crystallins expressed in fiber cells. Furthermore, only the epithelial cells have
metabolic activity; therefore, lens fiber cells cannot participate in protein turnover and
repair.[4] Among lens crystallins, a-crystallin serves as protein chaperone that prevents
aggregation of other crystallins. The chaperon activity of a-crystallin decreases with age,
so the lenses lose protection from degradation and oxidation of lens proteins with a
consequent increase in the scattering of light, thus forming cataracts.[5, 6]
a-crystallin is a hetero-dimer made by aA and aB crystallins that is usually
present as an oligomer of 10-15 hetero-dimers depending on the conditions.[7, 8] a-
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crystallin dimer are connected by two pairs of salt bridges at residues 120R and 109D.
The alpha crystallin domain (ACD), which also involves in the formation of dimer,
consists of a P-sandwich structure of 6 P-strands. aA and aB crystallin belong to the
small heat shock protein (sHsp) super family[9]. Members of the sHsp are found in all
forms of life and have a highly conserved alpha crystallin domain structure across
species. The sHsps are molecular chaperones that bind to unfolded or partially unfolded
proteins, preventing their interaction with other unstable proteins. The mini aA crystallin
is a recombinant peptide of aA crystallin 70-88 segment (mini-aA 70-88
KFVIFLDVKHFSPEDLTVK), and it shows chaperone activity.[10] The sHsp binds to
unstable (partly denatured) proteins and prevents them from aggregating, but the
denatured protein can only be restored to its native state in cooperation with other heat
shock proteins, such as ATP-driven Hsp70.[11]
In 2015, Zhao et al. [12]and Makley et al.[13] reported that lanosterol (LAN) and
25-hydroxycholesterol (25HD) restored the lens clarity. They claim those two sterols
interact with a-crystallin and enhanced the a-crystallin chaperone activity to such an
extent that the chaperone dissolves or disaggregates lens protein aggregates.
Following the studies of lanosterol and 25-hydroxycholesterol to restore lens’
transparency, other researchers tried to repeat those experiments or collect additional
experimental evidence about the activity of those sterols. The results are mixed. Chen et
al.[14] showed the lanosterol and 25-hydroxycholesterol in 5% DMSO effectively
redissolved human cataractous samples ex vivo with a EC50 (Half maximal effective
concentration) at 10 pM level. They concluded that those two sterols interact with
crystallins by different mechanisms, aggregates of all members of crystallins could be
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dissolved by lanosterol, but 25-hydroxycholesterol was only specific to a-crystallin,
which contradicts Makley e ta l.s findings[13]. Shen et.al.[15] found that, in vitro,
lanosterol (40 pM in M199 medium) delayed the occurrence of lens opacity in a
lanosterol synthase inhibited rat lens. Xu et.al.[16] used 20 pM lanosterol in 1% DMSO
to successfully reverse W151R mutant human pB2-crystallin aggregates. Kang et al. [17]
used all atom molecular dynamics simulation and free energy perturbation techniques to
show that lanosterol can bind to the hydrophobic interface of dimers of human yDcrystallins preventing aggregation. Yang et al. [18] successfully synthesized a series of
lanosterol derivatives and reported that a few of them reversed mutant crystallins induced
protein aggregation. Zhou et al. [19] reported that lanosterol (200 and 500 pM in PBS)
disrupts the fibrillation of amyloid-P peptides besides redissolving crystallin aggregates.
They further investigated the interaction of lanosterol and amyloid-P peptides by
molecular dynamics simulations, and then they concluded that lanosterol entangles with
the core segment of amyloid-P peptides and forms a hydrophobic core through aromatic
side chains. Chemerovski-Glikman et al.[20] found that 1 mM 25-hydroxycholesterol in
10% DMSO PBS but not lanosterol resulted in ~20% reduction of cataract solution (a
homogenized and resuspended crystallin precipitated) turbidity. Despite the encouraging
results obtained in in vitro experiments, the clinical trails and the in vivo experiments
using these two sterols have been unsatisfactory. Felici et.al.[21] reported that using 5
mM lanosterol in an olive oil eye drop given to patients with idiopathic unilateral juvenile
nuclear cataracts failed to dissolve cataract or halt the progress of lens opacification.
Nagai et.al. [22, 23] used lanosterol nanoparticles with a particle size distribution from 50
to 400 nm to repair the space and structural collapse in the early stages in the lenses.
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They found that it delays the onset of opacification of the lenses with a remarkable lens
structure collapse and opacification, but it does not repair them. They speculated that the
repeated injection of lanosterol nanoparticles attenuated the manifestation of cataractrelated factors and perhaps protects the lenses from oxidative stresses. Shanmugam et
al.[24] found that 25mM lanosterol in 20% ethanol fails to reverse nuclear opacity of
human cataractous nuclei after 6 days of incubation. Daszynski et al.[25] failed to repeat
the experiments by Zhao et al.[12] and Markley et al[13] using their same approach.
Also Daszynkski et al.’s docking simulations shows those two sterols cannot bind to the
groove which is formed by the a-crystallin dimer using two wild types (PDB 2WJ7 and
2KLR) and a R120G mutant (PDB 2Y1Z) aB-crystallin.
All efforts were focused on the restoration of cataractous crystallin aggregates,
but the effects of lanosterol and 25-hydroxycholesterol on the a-crystallin aggregation
process were not investigated. If the compounds could not avoid protein aggregation,
they could not solubilize aggregates. Furthermore, the influence of the two sterols on the
a-crystallin critical biological function and the chaperone activity were not studied. In
this paper, a series of studies were pursued to evaluate whether or not lanosterol and 25hydroxycholesterol prevented the a-crystallin aggregation and their effects on a native acrystallin chaperon activity using y-crystallin as substrate. a and y-crystallins are highly
stable at physiological conditions. The melting temperature of bovine a-crystallin and ycrystallin is approximately 61oC[26, 27] and 80oC[28, 29], but the turbidity of acrystallin and y-crystallin start to increase at around 65oC and 52oC[29]. a-crystallin starts
to lose secondary structure at approximately 60 oC[30]. For this study, a-crystallin was
incubated at 55 oC. The selection of incubation temperatures was based on the following
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considerations: 1) Temperatures above 60oC unfold a-crystallin secondary structures,
which changes the potential sterols interaction sites. Therefore, they should be avoided.

2) a-crystallin need long periods of time (up to months) to aggregate at temperatures
below 50oC, making the experiments not practical. Thus, 55oC was selected to be the
incubation temperature for a-crystallin. Unfortunately, the experiments to evaluate
chaperon activity happen too fast at 55 oC (within a week). Then, 50 oC was chosen to
evaluate the a-crystallin chaperone activity because at 50 oC, partially unfolded ycrystallin begins to bind to a-crystallin while the secondary structure of a-crystallin is
maintained.[31, 32]
To better understand the interactions, if any, between a-crystallin and sterols, we
studied the a-crystallin binding to Cu2+ in the presence of lanosterol and 25hydroxycholesterol. In addition of 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid,
dipotassium salt (bis-ANS) fluorescent assay, we explored the interaction between those
two sterols and the hydrophobic patches of the a-crystallin. The binding of Cu2+ to acrystallin is critical for a-crystallin. The chaperone activity of a-crystallin has been
enhanced upon Cu2+ binding[33-35]. The a-crystallin served as a collector of Cu2+ and
alleviate cytotoxic Cu2+ mediated oxidation[31, 34]. Cu2+ has been reported to bind to acrystallins through the mini-aA 70-88 peptide[36], the a-crystallin chaperone active
site[10]. The 4-(2-Pyridylazo)resorcinol (PAR) assay has been successfully used to
measure Cu2+ binding to a-synuclein[37] human aA-crystallin[31]. Therefore, any effect
of the sterols on the binding of Cu2+ is indirect evidence of them interacting with the acrystallin chaperone activity site. The bis-ANS is a fluoresce probe which binds to
proteins through interaction with the aromatic rings.[38] Ghahramani et a/.[33], Ghosh
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et al. [31] and Raju et al. [36] have shown binding of Cu2+ to a-crystallin has lower the
bis-ANS fluorescence intensity. Raju et al. pointed out the bis-ANS binds to the mini aAcrystallin 70-88. And the histamine (H) at position 79 is the binding site for Cu2+.

2. MATERIALS

Fresh bovine lenses were purchased form Animal Technologies, Inc. (Tyler, TX,
US) and stored at -20oC in a storage buffer: 1% 2-mercapthanol, 0.245 M acetate buffer
at pH 5.0. Bulk lanosterol (55% purity), 25-hydroxycholesterol (>98% purity), 4,4'dianilino-1,1'-binaphthyl-5,5'-disulfonic acid, dipotassium salt (bis-ANS) fluorescence
probe, 4-(2-Pyridylazo)resorcinol (PAR), GC grade dimethyl sulfoxide (DMSO),
guanidine hydrochloride (GdnHCl) and CuCh were purchased from Sigma-Aldrich (St.
Louis, MO, US). Cu2+ standard solution was purchased from Acros (Fisher Scientific,
Hampton, NH, US). Ultrafiltered type 1 water (>18.0 MOhm/cm) was used in all
experiments. The other chemicals were analytical grade.

3. METHODS

3.1. BOVINE a-AND y-CRYSTALLIN ISOLATION
One bovine lens was thawed in water at room temperature and then homogenized
in 0.05M Tris pH 7.4 buffer. The homogenate was centrifuged at 15,000 xg at 4oC. The ycrystallin was separated from a- and P-crystallin by running the supernatant through a
Sephadex G-75 gel permeate column (GPC) (2.5 x 60 cm) with 0.05M pH 7.4 Tris buffer
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as mobile phase. The flow rate was 0.5 ml/min, and the Uv detector was set as 280 nm.
The pooled y-crystallin and the mixture of a- and P-crystallins were dialyzed against
reverse osmosis (RO) water for 24 hours with water changes every 8 hours at 4oC. After
dialysis, the samples were lyophilized and stored at -20oC. The a-crystallin fraction was
separated from P-crystallin with a Sephadex G-200 GPC (2.5 x 60 cm) column using the
same buffer as mobile phase, but the flow rate was changed to 0.1 ml/min. The acrystallin fraction was dialyzed, lyophilized, and stored at -20oC.

3.2. LANOSTEROL ISOLATION AND 25-HYDROXYCHOLE STEROL
The bulk lanosterol was purified by a method from previous work.[39] Briefly,
one milliliter of saturated crud lanosterol solution in methanol was injected to an AKTA
purifier FPLC (Marlborough, MA, US) equipped with C18 reverse-phase column (4.6
mm x 150 mm). The mobile phase was methanol at a flow rate of 2.0 ml/min. Pure
lanosterol was collected and then vacuum-oven dried at 60oC. The 25-hydroxycholesterol
was used as ‘received’ without further purification.

3.3. a-CRYSTALLIN AGGREGATION WITH AND WITHOUT LANOSTEROL
AND 25-HYDROXYCHOLESTEROL
The following samples were prepared: a-crystallin only, a-crystallin with 5%
DMSO, a-crystallin with 5% DMSO and lanosterol, a-crystallin with 5% DMSO and 25hydroxycholesterol. The a-crystallin powder was dissolved in 0.1M pH 7.4 phosphate
buffer at a concentration of 5.0 mg/ml. Lanosterol and 25-hydroxycholesterol were
dissolved in DMSO at 1.0 mg/ml. Fifty microliters of each sterol stock solutions were
then mixed with the a-crystallin solution to achieve sterols’ final concentrations of 125
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pM in the high concentration sterols experiments. In the low sterol concentration
experiments, the final sterols concentrations were 0.5 pM and 45 pM for lanosterol and
25-hydroxycholesterol, respectively. For the control samples, 50 pL of DMSO or
phosphate buffer were added, instead of the sterol solutions. The samples were
transferred to the 2 mL polypropylene test tubes with screw caps, and sealed with
Parafilm M (American National Can, Chicago, IL), and then they were incubated on a
dry bath at 55oC. The experiments were done in triplicate.

3.4. DYNAMIC LIGHT SCATTERING (DLS)
The particle size distribution of a-crystallin (5.0 mg/ml), lanosterol (0.5pM and
125pM in 5% DMSO), 25-hydroxycholesterol (45pM or 125pM in 5% DMSO), or a
mixture of a-crystallin and the two sterols in 0.1M pH 7.4 phosphate buffer were
measured using fiber optic quasi elastic light scattering (FoQels) (Brookhaven
Instruments. Holtsville, NY, US). The instrument operated at 25oC. The laser wavelength
was 830 nm, and the detector had a back angle of 135.9o. The samples were put in a glass
cylindrical cuvette with a diameter of 1 cm. The correlation function was obtained after
scanning for 2 minutes, and it fitted with the CONTIN algorithm. The particle size
distribution were calculated by intensity and by number.

3.5. EVALUATION OF a-CRYSTALLIN CHAPERON ACTIVITY WITH yCRYSTALLIN WITH LANOSTEROL AND 25-HYDROXYCHOLESTEROL
The following samples were prepared: y-crystallin, y-crystallin+ a-crystallin (1:2),
y-crystallin+ a-crystallin (1:2) with 5% DMSO, y-crystallin+ a-crystallin (1:2) with 5%
DMSO and lanosterol, y-crystallin+ a-crystallin (1:2) with 5% DMSO and 25-
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hydroxycholesterol. The a-crystallin and y-crystallin were dissolved in 0.1M pH 7.4
phosphate buffer at final concentrations of 2.0 mg/ml and 1.0 mg/mL for a-crystallin ycrystallin, respectively (a : y 2:1). Fifty microliters of each sterol stock solution was then
mixed with a-crystallin- y-crystallin solutions to obtain sterols at a final concentration of
125 pM in the high concentration sterols experiments. In low sterols concentration
experiments, the final sterol concentrations were 0.5 pM and 45 pM for lanosterol and
25-hydroxycholesterol, respectively. For control samples, 50 pL of DMSO or phosphate
buffer were added. The samples were transferred to the 2 mL polypropylene test tubes
with screw caps, then sealed with Parafilm M and they were incubated on a dry bath at
50oC. The experiments were done in triplicate.

3.6. TURBIDITY
The turbidity of the samples was monitored by a Genesys 5 spectrophotometer
(Thermo Fisher Scientific Inc. Waltham, MA, US) at 600 nm. The temperature was
controlled by a thermostatic bath at 55oC or 50oC. Samples of 0.8 mL were quickly
transferred to the polystyrene disposable semi-micro cuvettes with open tops for turbidity
measurements. Blanks were subtracted and averages calculated. The lag-time, flag, and
growth-rate, g r, were extracted by fitting the equation[40] below to turbidity data:
F=

F_
(1 + ve-k(f-f”Y v

(1)

where F is the turbidity at 600nm, Fmax is the maximum turbidity at the steady-state, fm is
the point of maximum growth rate, and v describes the asymmetry of the sigmoid curve.
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The growth rate (gr ) is given by k / (1 + v) and the lag-time (tiag) is calculated from: tm (1 + v)/k, which is the time where the tangent at tm crosses the lag-phase baseline.[41]

3.7. MONITORING THE SOLUBLE FRACTION BY HPLC
A Shimadzu HPLC system (Nakagyo-ku, Kyoto, Japan) equipped with a Biobasic
300 size exclusion column was used to monitor the concentration of the soluble fraction.
The Uv-vis detector was set at 280 nm. The mobile phase was 0.1 M pH 7.4 phosphate
buffer running at 1.0 ml/min. Samples were first centrifuged at 15,000 xg at 4oC for 5
minutes, then the supernatant was sampled and diluted. The a-crystallin samples were
diluted at 12.5x, and a-crystallin + y-crystallin samples were diluted at 5x. Ten pL of the
samples were injected.

3.8. FOURIER-TRANSFORM INFRARED SPECTROSCOPY (FTIR)
The secondary structure of crystallins was monitored using a Nicolet 6700 FTIR
(Thermo Fisher Scientific Inc. Waltham, MA, US) spectrophotometer. Before
measurement, the spectrophotometer was purged with dry air, and liquid nitrogen was
added to the detector. That was followed by 40 minutes of equilibration. Twenty pL of
each sample was dried on a CaF2 window using a fan for 5~10 minutes. The CaF2
window was then put in the measuring chamber. A five minute re-equilibration time was
given for each time the chamber was opened. The range of 4000 cm-1 to 1000 cm-1 was
recorded at 64 scan with 8 cm-1 resolution. Amid I peak, 1700 cm-1 to 1600 cm-1 of each
spectrum was deconvoluted using Origin 2016. The peaks from the deconvolved spectra
were assigned to specific secondary structures according to previous studies.[42-44]
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3.9. CIRCULAR DICHROISM SPECTROSCOPY (CD)
The 5 mg/ml a-crystallin samples were incubated with 125 ^M of lanosterol or
25-hydroxycholesterol at 37 oC for 2 hours. Then, they were loaded on a G-75 GPC
column to remove unbound sterols, using 0.1 M pH 7.4 phosphate buffer as the mobile
phase and a flow rate of 1 ml/min. The a-crystallin fractions were collected and the
concentration was measured at 280 nm with an extinction coefficient of A 1%2 8 0 = 8.42.
The concentration of a-crystallin was then adjust to 0.3mg/ml for far UV-CD and 2.0
mg/ml for near UV-CD. The far UV-CD spectra were recorded using a JASCO J-815
spectropolarimeter (Easton,MD, USA) at 25oC in a 0.2 cm path length quartz cell from
200 to 250 nm. The near UV-CD spectra were recorded from 250nm to 340nm with same
instrument, but the protein concentration was changed to 2.0 mg/ml and a 1.0 cm path
length quartz cell was used. The spectra of proper blanks were subtracted from each
protein spectrum. The spectra were analyzed using the BeStSel online sever.[45, 46]

3.10. COPPER ION BINDING OF A-CRYSTALLIN IN THE PRESENCE OF
LANOSTEROL AND 25-HYDROXYCHOLESTEROL, 4-(2-PYRIDYLAZO)
RESORCINOL (PAR) ASSAY
The PAR assay was adapted from Ghosh et a/.[31] The excess amount of CuCh
was added to a 0.1 M pH 7.4 phosphate buffer with 5 mg/ml a-crystallin. Then, 50 p,L of
DMSO or sterols DMSO solution was added to achieve 125 ^M for high concentration of
those two sterols, 0.5 ^M for low concentration of lanosterol, and 45 ^M for low
concentration of 25-hydroxycholesterol. After 2 hours of stirring and incubation at 37oC,
the samples were centrifuged at 1000 xg to sediment the excess amount of CuCh. The
supernatant was loaded on a Sephadex G-75 GPC (2.5 x 30 cm) column to remove
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unbound Cu2+, using 0.1 M pH 7.4 phosphate buffer as the mobile phase and a flow rate
of 1 ml/min. The a-crystallin fractions were collected and the concentration was
measured at 280 nm with an extinction coefficient of A 1% 280= 8.42. Then, the
supernatant was treated for five minutes with 4M GdnHCl to denature the a-crystallin
and release the copper ion. After which, 10 pL of a freshly prepared PAR dye solution
was added to each sample with a final concentration of the dye at 100 pM. The
absorbance at 514nm was recorded and subtracted from the control sample, which had
4M GdnHCl and PAR. Cu2+ content was calculated from:

Cu2+(p M) = 24.33AA514nm+ 1.049

(2)

Equation 2 was obtained by measuring a series of Cu2+ standard solution (Acros
Organics) using PAR.

3.11. BIS-ANS FLUORESCENT ASSAY
The samples were prepared by the same procedures described in the PAR assay.
The samples after GPC were diluted to 15pM of a-crystallin. That was followed by
addition of 10 pL of bis-ANS stock solution (14.8 pM in 95% ethanol) to reach a final
bis-ANS concentration of 0.148 pM. The samples were then incubated at 37oC for 20
minutes. The bis-ANS fluorescence was monitored using a Nanodrop 3000
fluorospectrometer (Thermo Fisher Scientific Inc. Waltham, MA, US) with an excitation
wavelength of 390 nm and the emission spectrum were recorded from 395 nm to 751 nm.
Each sample was measured 9 times and the fluorescence intensity at 490 nm was
averaged.
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4. RESULTS

4.1. DYNAMIC LIGHT SCATTERING
The solubilities of lanosterol and 25-hydroxycholesterol in 5% DMSO are not
available. First we measured the solubility of the two sterols according to Li and
Forciniti.[39] They are 0.5 pM for lanosterol and 45 pM for 25-hydroxycholesterol,
respectively. Therefore, at a concentration of 125 pM (the high sterols samples used in
this study), the high sterols samples used in this study consist of undissolved sterol at
equilibrium with a saturated solution. Figures 1 A- D show the particle hydrodynamic
diameters distribution by number and by intensity of the two sterols at 125 pM in 5%
DMSO phosphate buffer without a-crystallin. The hydrodynamic diameters calculated by
number and by intensity were similar. Both sterol “solutions” have large undissolved
particles. The hydrodynamic diameter of lanosterol and 25-hydroxycholesterol were
around 1500 nm and 3500 nm. Figures 1 I-L showed the low concentration sterols
samples with a-crystallin. The hydrodynamic diameters calculated by number and by
intensity were similar. The only detectable particle is a-crystallin, which has a
hydrodynamic diameter around 10nm, which was the same of a-crystallin (data not
shown). Figures 1E - H showed that by adding a-crystallin to high concentration sterols
solutions, the particle size distributions calculated by number and by intensity were
different. The particle size distribution calculated by intensity showed that particle
diameter of undissolved 25-hydroxycholesterol (Figure 1H) decreased to approximately
600 nm, however, the undissolved lanosterol particle diameter (Figure 1F) barely
changed. The particle diameter distribution of lanosterol with a-crystallin calculated by
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number was approximately 120 nm and for 25-hydroxycholesterol, which was
approximately 17 nm (Figure 1 E and G). Those results suggested that there were two
sets of particles in the samples: 1) one set of small particles with a large population that
correspond to a-crystallin and 2) a set of large particles with a small population that
corresponds to the undissolved sterols. The hydrodynamic diameter of a-crystallin
increased upon addition of high concentration of the sterols, which suggests that acrystallin forms large aggregates in the presence of undissolved sterols particles.

Figure 1. Dynamic light scattering (DLS) of lanosterol and 25-hydroxycholesterol in 5%
DMSO phosphate buffer 0.1M pH 7.4. Left panel: by number; Right panel: by intensity.
A and B, 125uM lanosterol. C and D, 125pM 25-hydroxycholesterol. E and F, 5mg/mL
a-crystallin+ 125pM lanosterol. G and H, 5mg/mL a-crystallin+ 125pM 25hydroxycholesterol. I and J, 5mg/mL a-crystallin+ 0.5pM lanosterol. K and L, 5mg/mL
a-crystallin+ 45pM 25-hydroxycholesterol
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Figure 2. Turbidity of a-crystallin or a-crystallin and y-crystallin mixture in 0.1M pH 7.2
phosphate buffer. A, turbidity o f a-crystallin incubated with 125pM sterols at 55oC. B,
turbidity o f a-crystallin incubated with 0.5pM lanosterol or 45pM 25-hydroxycholesterol
at 55 oC. C, turbidity of a-crystallin and y-crystallin incubated with 125pM sterols at 50
oC. D, turbidity of a-crystallin and y-crystallin incubated with 0.5pM lanosterol or 45pM
25-hydroxycholesterol at 50 oC

Figures 2 C and D show the aggregation kinetics of a-crystallin and y-crystallin
mixtures. The lag-times and growth rates are summarized in Figure 3 B and D. The
samples that only had y-crystallin aggregated within half an hour at 50 oC. The samples
that had a-crystallin yielded longer lag-times and slower growth rates, which
demonstrated the a-crystallin chaperone activity. Compared to the samples of a-crystallin
and y-crystallin without DMSO, the samples with 5% DMSO had longer lag-times and
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slower growth rates, which again may be due to the preferential hydration of the protein
caused by DMSO. The lag-times for the samples with high concentration of both sterols
decreased drastically, but the growth rates were slower than in the DMSO control. The
lag-times and growth rates for low sterol concentration samples were not significantly
different from the DMSO controls.

a-cystallin

a-cystallin

a-cystallin

+ 5% D M S0

+5%DMS0 + 5%DMS0
+ 5%DMS0
+126HMLAN +125jjM 25-HD +0.5pM LAN

a-cystallin

a-cystallin

a-cystallin

+5%DMS0
+45^M 25-HO

y-crystallin ,',+a

yta
+5% DMSO

rnt
+5SDMS0
+125jiM LAN

Y+a
+5% DMSO
+5% DMSO
+125jjM 25-HD +0 5^M LAN

'!+a

T+a
+5% DMSO
+45nM 25-HD

Figure 3.Lag-time and growth rate of a-crystallin or a-crystallin and y-crystallin mixture
aggregation kinetics. A and C, lag-time and growth rate of a-crystallin. B and D, lag-time
and growth rate of a-crystallin and y-crystallin mixture
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4.2. SOLUBLE FRACTION
The soluble fraction of a-crystallin incubated with high concentrations of the two
sterols was plotted together with turbidity data (Figure 4A). The soluble fraction of acrystallin decreases as the turbidity increases. The soluble fraction of samples without
DMSO decreases faster than the samples with DMSO as observed in the turbidity
measurements. The retention times of a-crystallin (Figure 4B) were shorter upon heating,
which implies that the apparent molecular weight of a-crystallin has increased. The
increase of a-crystallin apparent molecular weight upon heating has been reported by
Putilina et.al.[50] who used gel filtration and small angle x-ray scattering (SAXS). That
increase in the apparent molecular weight a-crystallin may also be the reason for the
decrease in the soluble fraction at the beginning of heating. The decrease in the soluble
fraction began at around 24 hrs when the turbidity was still in the lag-phase may reflect
the lost of soluble aggregates during centrifugation prior to HPLC analysis. At around
~250 hrs, there is an inverse correlation between the amount of the soluble fraction and
turbidity values, i.e., the soluble fractions of the sample with DMSO are in the order of
a-crystallin+ 125gM 25-hydroxycholesterol > a-crystallin > a-crystallin + 125gM
lanosterol, but the order of for the turbidity values is inversed.
Figure 5A shows that the soluble fraction of a-crystallin incubated with low
concentration of the two sterols. In this case, the soluble fraction of a-crystallin was not
significantly different from the control sample (a-crystallin in 5% DMSO). Figure 5B
shows that the retention times of the a-crystallin were similar to the 5% DMSO control.
Figure 6A-C shows the soluble fraction of the a-crystallin and y-crystallin
mixtures incubated with high concentration of the sterols. The total soluble fraction
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Figure 4. The a-crystallin incubated with 125gM lanosterol or 25-hydroxycholesterol. 1,
a-crystallin control. 2, a-crystallin 5% DMSO control. 3, a-crystallin+ 125gM lanosterol
in 5% DMSO. 4, a-crystallin+ 125gM 25-hydroxycholesterol in 5% DMSO. A, soluble
fraction of a-crystallin. B, retention time of a-crystallin. C, P-sheet content. D, turns and
coil content

Figure 5. The a-crystallin incubated with 0.5gM lanosterol or 45gM 25hydroxycholesterol. 1, a-crystallin control. 2, a-crystallin 5% DMSO control. 3, acrystallin+ 0.5gM lanosterol in 5% DMSO. 4, a-crystallin+ 45gM 25-hydroxycholesterol
in 5% DMSO. A, soluble fraction of a-crystallin. B, retention time of a-crystallin. C, Psheet content. D, turns and coil content

Turns and coil content/ %

y-crystallin soluble fraction %
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Figure 6. The a-crystallin and y-crystallin mixture incubated with 125gM lanosterol or
25-hydroxycholesterol. 1, y-crystallin. 2, a-crystallin and y-crystallin mixture (2:1)
control. 3, a-crystallin and y-crystallin mixture (2:1) 5% DMSO control. 4, a-crystallin
and y-crystallin mixture (2:1)+ 125gM lanosterol in 5% DMSO. 5, a-crystallin and ycrystallin mixture (2:1)+ 125gM 25-hydroxycholesterol in 5% DMSO. A, total soluble
fraction. B a-crystallin soluble fraction. C, y-crystallin soluble fraction. D, retention time
of a-crystallin. E, P-sheet content. F, turns and coil content

includes both soluble a-crystallin and y-crystallin, and it decreased as the turbidity
increases (Figure 6A). The soluble fraction data are compared against turbidity in Figures
6B and C. The y-crystallin soluble fraction drastically decreases within 50 hours, but the
turbidity of the samples with a-crystallin is still in the lag phase, which demonstrates acrystallin chaperone activity. Putilina and co-workers[50] also showed that a-crystallin
prevent y-crystallin from aggregation. The y-crystallin soluble fraction decreased faster in

118
the samples with 5% DMSO than the samples without DMSO (Figure 6C); i.e., at
approximately 50 hours, the a+y without DMSO had around 50% y-crystallin soluble
fraction and the samples with DMSO had around 30% y-crystallin soluble fraction.
Therefore, DMSO promotes unfolding of the y-crystallin. The unfold y-crystallin bound
to a-crystallin to form a/y complex within 9 hours at 55 oC.31 Therefore, the soluble
fraction of a-crystallin included a-crystallin and a/y complex. In Figure 6C, the soluble
fraction of y-crystallin with high concentration of sterols decreased to 30% within 50
hours. The turbidity is also increased but not to the extent of the samples containing only
y-crystallin. Figure 6B shows that the a-crystallin soluble fraction also decreased in the
samples containing high concentrations of sterols. Therefore, the increase in turbidity is
mainly caused by the loss of a-crystallin or the a/y complex. Compared to the a-crystallin
turbidity data, the a/y complex has a higher aggregation propensity. In spite of the fact
that a-crystallin was incubated at higher temperatures (55oC vs 50oC) and higher
concentrations (5 mg/mL vs 3 mg/mL). Figure 6D shows that the retention time of acrystallin first decreases to a minimum, and then increased. The decrease in a-crystallin
retention time indicates that the apparent molecular weight of a-crystallin increases by
forming higher oligomers and by binding to unfolded y-crystallin.[50] The minimum
retention time appeared at the end of the growth phase of each sample. It indicated there
was remaining soluble low molecular weight a-crystallin in the solution.
Figure 7A-C show the soluble fraction of a-crystallin and y-crystallin incubated
with low concentration of lanosterol or 25-hydroxycholesterol. Figure 7D shows the
retention time of a-crystallin vs incubation time. No major differences were found
between samples containing sterols and DMSO controls.
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Figure 7. The a-crystallin and y-crystallin mixture incubated with 0.5gM lanosterol or
45gM 25-hydroxycholesterol. 1, y-crystallin. 2, a-crystallin and y-crystallin mixture (2:1)
control. 3, a-crystallin and y-crystallin mixture (2:1) 5% DMSO control. 4, a-crystallin
and y-crystallin mixture (2:1)+ 0.5gM lanosterol in 5% DMSO. 5, a-crystallin and ycrystallin mixture (2:1)+ 45gM 25-hydroxycholesterol in 5% DMSO. A, total soluble
fraction. B a-crystallin soluble fraction. C, y-crystallin soluble fraction. D, retention time
of a-crystallin. E, P-sheet content. F, turns and coil content
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4.3. SECONDARY STRUCTURES MONITORED BY FTIR
The protein secondary structures were monitored by FTIR through the
aggregation processes. The Amide I peaks were deconvoluted. Figure 8 shows an
example of the deconvolution of the Amide I peak, which were at the beginning and at
the end of the a-crystallin that was incubated with 125 pM lanosterol at 55oC. The
deconvoluted peaks were assigned to the following secondary structures: 1630 and 1691
cm-1 are P-sheet, 1641 cm-1 is a-helix, 1661 cm-1 is turns and 1676 cm-1is random
coil.[42-44] The area percentages for each deconvoluted peak were used to represent the
content of each secondary structure.

Figure 8. Examples of FTIR Amid I spectra deconvolution. The red lines are second
derivative of Amid I peak. The black slid line is the sums of the deconvoluted peaks, and
the dash line represent the deconvoluted peaks. The peaks are: 1630 and 1691 cm-1 are Psheet, 1641 cm-1 is a-helix, 1661 and 1676 cm-1 are turns and random coil. A, a-crystallin
+ 125pM lanosterol before incubated at 55oC. B, a-crystallin + 125pM lanosterol
incubated at 55oC for 460 hours
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Figure 4 C and D and Figure 5 C and D show the percentages of P-sheet and turns
and coil of a-crystallin vs incubation time. The native a-crystallin secondary structure
contents were a-helix: 15%, P-sheet: 45% and turns and random coil: 40%, which agree
with previous publications.[30, 47] The P-sheet decreased slightly from 45% to 42%
during the incubation. The percentages of the turns and random coil increased from 39%
to 42%. The a-helix stayed at approximately 15% throughout incubation. No significant
changes to the secondary structure of a-crystallin at 55oC were expected because
previous tests showed the significantly loss of a-crystallin secondary structures usually
been seen above 60oC.[30] The changes to a-crystallin secondary structure of the samples
containing both sterols were similar to the DMSO controls, regardless of high or low
sterol concentration.
Figure 6 E and F and Figure 7 E and F show P-sheet and turns and random coil
percentages verse incubation time of a-crystallin and y-crystallin samples. The
deconvoluted peaks of native y-crystallin were: 1638 cm-1 and 1690 cm-1 (P-sheet, 58%),
1661 cm-1 (a-helix 20%) and 1675 cm-1 (turns 21%). The secondary structure contents of
the y-crystallin measured in this study were similar to previous publication.[48] After
incubating for 24 hours, a set of new peaks were found: 1618 and 1634 were assigned to
P-sheet (30%), 1651 was assigned to random coil (32%), 1670 and 1682 were assigned to
turns (39%). At the end of incubation (260 hours), the a-helix of y-crystallin was
completely lost, the percentage of P-sheet content was reduced to 22%, and the turns and
coil contents were raised to 78%. In the samples containing both a-crystallin and ycrystallin, the infrared signal was a combination of both crystallins. The P-sheet content
was reduced from 47% to 38%, and the turns and coil contents were increased from 39%
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to 46%; the a-helix still held at approximately 15%. This study argued that these changes
were caused by the unfolding of gamma-crystallin. The secondary structure contents of acrystallin and y-crystallin had no significant differences between the samples containing
lanosterol and 25-hydroxycholesterol and the DMSO controls.

4.4. Cu2+ CONTENT OF a-CRYSTALLIN
Figure 9 shows the Cu2+ content of a-crystallin with and without the two sterols
measured by PAR assay. The a-crystallin isolated for this study in the lab had no Cu2+
content (data not shown). Figure 9 shows that neither high nor low concentrations of the
two sterols had effect on the Cu2+ binding capacity of a-crystallin. The a-crystallin bound
to Cu2+ at a ratio of 1:3, which was lower than the mini aA-crystallin 70-88 that bound to
Cu2+ at a ratio of 1:1 [36], and the recombined human aA-crystallin bound at (1:2).[31]
The Cu2+ binding capacity of a-crystallin oligomers is lower than the one for the mini
aA-crystallin monomer,[36] and the one for recombinant aA-crystallin since the
recombinant protein forms oligomers of different size.[49] And the incubation time and
temperature may affect the binding. The mini aA-crystallin incubated with Cu2+ for 30
minutes at 25 oC and recombinant aA-crystallin incubated with Cu2+ for 9 hours at 55 oC.
Figure 10A shows the fluorescence spectra of bis-ANS. The fluorescence
intensity of 490nm of each sample is summarized in Figure 10B. The results were sorted
into two groups: with Cu2+ and without Cu2+. Adding Cu2+ lowered the bis-ANS
fluorescence intensity.The mini aA-crystallin region 70-88
KFVIFLDVKHFSPEDLTVK bound Cu2+ through 79 His[36] that was negatively
charged at pH 7.4. The 71 Phe, 74 Phe and 80 Phe may interact with bis-ANS through the
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aromatic side chains[38]. The Cu2+ and bis-ANS probe competed for the binding
sites[36]. The lanosterol and 25-hydroxycholesterol had no significant effect on the bisANS fluoresce intensity, regardless of high or low sterol concentration.

a-crystallin

a-crystallin a-crystallin a-crystallin a-crystallin a crystallin
+DMSO

+DMSO
+ 125|.iM
LAN

+DMSO
+0.5 mM
LAN

+DMSO
+125|.i M
25-HD

+DMSO
+45 jiM
25-HD

Figure 9. The Cu2+ content of a-crystallin. The a-crystallin incubated with access amount
of Cu2+, then separated by GPC. The Cu2+ content was measured by PAR assay. 25-HD
represent the 25-hydroxycholesterol

4.5. CIRCULAR DICHROISM
To corroborate the FTIR-based protein secondary structures, far-Uv CD
measurements were used (Figure 11). The a-crystallin incubated with 125pM lanosterol
or with 25-hydroxycholesterol was loaded on a G-75 GPC to remove particles that
interfered with the CD measurements. As shown in the Figure 11B, the secondary
structures of samples incubated with sterols and of DMSO control samples showed no
significant differences. Therefore, the secondary structure contents were similar to the
results of FTIR. In the near-Uv CD spectra, shown in Figure 12. The tertiary structure of
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the samples with the two sterols had no significant difference compared to the DMSO
control samples.

Figure 10. bis-ANS fluorescence spectra of a-crystallin. A, bis-ANS fluorescence spectra
of 15pM a-crystallin. The a-crystallin incubated with sterols or controls for 2 hours then
separated by GPC. The blank of 30pM bis-ANS in phosphate buffer was subtracted. B,
the fluoresce intensity at 490 nm
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Figure 12. Near-UV CD spectra of a-crystallin with 125 ^M lanosterol or 125 ^M 25hydroxycholesterol and controls
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5. DISCUSSIONS

a-crystallin has internal cavity structures,[50, 51] which may trap small
molecules,[52] such as dexamethasone,[52] 1-anilinonaphthalene-8-sulfonic acid
(ANS)[53] and acrylamide.[54] Augusteyn et a/.[52] concluded that this phenomenon
was a nonspecific partitioning. By analogy, the solubilization of 25-hydroxycholesterol
by a-crystallin was reported by Puttur et a/.,[25] who explained the solubilization by
speculating that 25-hydroxycholesterol was trapped by a-crystallin oligomers, but not
lanosterol. It is not known why lanosterol does not partition into the same cavities. Our
DLS measurements show that the undissolved particle size of 25-hydroxycholesterol was
reduced from 3500 nm to 600 nm by adding a-crystallin (Figures 1 D and H). On the
contrary, the undissolved particle size of lanosterol was not significantly affected by the
addition of the a-crystallin (Figures 1 B and F). Therefore, reduction of the undissolved
25-hydroxycholesterol particle size may be due to the nonspecific partitioning whereas
lanosterol does not partitioned in agreement with Puttur et aTs hypothesis.
Lanosterol and 25-hydroxycholesterol failed to prevent a-crystallin aggregation.
Moreover, at sterol concentrations of 125 pM, a-crystallin aggregation was promoted.
The turbidity of a-crystallin incubated with low concentration of the two sterols, showing
that the sterols do not change the aggregation kinetics. The a-crystallin chaperone activity
was not affected by low concentrations of the two sterols. This indicated that completely
dissolved lanosterol or 25-hydroxycholesterol did not interact with a-crystallin. In the
turbidity data with high concentration of lanosterol or 25-hydroxycholesterol, the lagtimes were shorter than the DMSO control samples, which implied that the solid sterol
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particles served as nucleation sites. Based on the DLS measurements, the solutions
containing high concentration sterols had large undissolved particles that may have
affected the aggregation kinetics.
The a-crystallin chaperone activity was evaluated by using y-crystallin as
substrate. The lag-times for a+ y-crystallin samples with high concentration of the two
sterols were shorter than the time yielded by the DMSO control. The undissolved sterol
particles altered the aggregation kinetics. Figure 6B and C show that the increase in
turbidity was caused by a/y complex or a-crystallin precipitation. Because the turbidity of
the high concentration sterols samples did not increase as fast as the y-crystallin control
samples, so it was concluded that increase in turbidity was due to decreases in the soluble
fraction of a-crystallin and a/y complex. The two sterols promoted the aggregation of a/y
complex and a-crystallin. The chaperone activity o f a-crystallin was not affected by the
lanosterol or 25-hydroxycholesterol. This conclusion was further supported by the PAR
and bis-ANS assay that the chaperone activity sites were not affected by the two sterols,
regardless of high or low concentrations of the two sterols.
The a-crystallin samples incubated with high concentration of the two sterols
were selected to be assessed by CD measurements because high concentration of sterols
changed the aggregation kinetics. The 125 pM of lanosterol or 25-hydroxycholesterol did
not change the secondary structures of a-crystallin, which was confirmed by far UV-CD
and FTIR. The near UV-CD spectra showed that the tertiary structures of a-crystallin
were not affected by high concentration of the two sterols either.
The PAR assay showed the Cu2+ content of a-crystallin was not affected
regardless of the sterol concentration used. Therefore, the chaperone binding sites of

128

alpha-crystallin were not occupied by the sterols. However, the binding to other sites
cannot be excluded, but that can be addressed by looking at the bis-ANS assays. The bisANS bound to hydrophobic sites on the a-crystallin that included the Cu2+ binding site.
The bis-ANS fluorescence intensity of samples incubated with Cu2+ was not affected by
the two sterols. That confirmed the result of the PAR assay that stated that the two sterols
did not affect the Cu2+ binding capacity of a-crystallin. The bis-ANS fluorescence
intensity of the samples incubated without Cu2+ was not affected by the two sterols in any
concentration. It can be stated that the sterols did not bind to the chaperone site. The bisANS and the Cu2+ competed for the chaperone binding site, which was the mini aAcrystallin region. The affinity of bis-ANS was weaker than that of Cu2+. The possibility
of the sterols having weaker interactions than the bis-ANS with the chaperone binding
site was not ruled out by this study.
The a-crystallin dimer interface was another potential binding site for sterols
beyond the chaperone binding site. Makley et al. [13] and Daszynski et al. [25] studied the
possible interactions between 25-hydroxycholesterol or lanosterol and the a-crystallin
dimer interface by docking simulations. Both of them predicted the Kd (dissociation
constant that is the ligand concentration at which half the protein molecules will have a
ligand bound) of the two sterols were in the high micromolar or even millimolar range;
i.e. Kd values for lanosterol-2KLR (wildtype aB-crystallin) and 25-hydroxycholesterol
dimer interface were 73.63 mM 25-hydroxycholesterol and 1.22 mM, respectively.[25]
Daszynski et al. [25] concluded that this high concentration of the two sterols could not be
achieved clinically in the lens. Based the experimental results of this study and the
conclusion from Daszynski et al., the interactions, if any, between lanosterol or 25-
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hydroxycholesterol and a-crystallin are not specific. The presence of undissolved sterols
particles that served as aggregation nuclei may be the reason that the undissolved sterols
promoted a-crystallin and a/y complex aggregation.

6. CONCLUSIONS

In this study, it was found that lanosterol and 25-hydroxycholesterol failed to
prevent a-crystallin aggregation induced by heating. Sterol concentration of 125pM
promoted the aggregation of a-crystallin and of the a/y complex possibly by serving as
nucleation sites. The chaperone activity of a-crystallin was not affected by the two
sterols, which suggested that the sterols did not bind to the chaperone binding site. This
was confirmed by the bis-ANS results. FTIR and far-UV CD analysis showed that the
secondary and tertiary structures of a-crystallin were not affected by the presence of the
two sterols, regardless of their concentrations. Furthermore, the two sterols had no
significant effect on the Cu2+ or on the bis-ANS binding capacity of a-crystallin.
Therefore, hydrophobic sites were not interaction sites for the two sterols and acrystallin. Thus, no evidence was been found that the two sterols interacted specifically
with the a-crystallin.
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SECTION

2. CONCLUSIONS AND FUTURE WORK

2.1. CONCLUSIONS
This dissertation covers a range of topics all related directly or indirectly to
protein solubility and its consequences during the processing of proteins or in human
health. A considerable effort was put in a supportive study (solubility o f sterols) because
the data was needed to better understand the effect of sterols in protein solubility. The
main conclusions of this work as summarized in the following paragraphs.
In paper I, glycosylated and non-glycosylated mAbs were precipitated by PEG.
Effects of PEG molecular weight, pH, and temperature were studied. The glycosylated
mAbs had higher solubility than non-glycosylated mAbs in all conditions. Although
glycosylation increases the molecular weight of mAbs the glycosylated mAbs required
higher amounts of PEG to precipitate, which contradicts the predictions of excluded
volume theory. Glycosylation had major effects on the PEG precipitation efficiency but
not on the onset precipitation point. The lectin and mAbs were found to form a hetero
complex at several pH levels due to electrostatic attractions. A few solubility models used
in this work were not able to explain the effect o f glycosylation or protein solubility.
In paper II, the solubility of lanosterol in organic solvents and water-alcohol
binary systems was measured at different temperatures. The activity coefficient models of
Wilson, NRTL and UNIQUAC correlated the experimental data satisfactorily. The
Apelblat -Jouyban-Acree and the van’t Hoff-Jouyban-Acree models correlated water-
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alcohol binary systems without significant deviations. The lanosterol solubility data
collected in this paper showed that the lanosterol concentration used in crystallins
aggregates restoration experiments was exceeded the solubility limit of the sterol.
In paper III, it was found that lanosterol and 25-hydroxycholesterol failed to
prevent a-crystallin aggregation upon heating. A concentration of 125pM of the two
sterols promoted the aggregation of a-crystallin and of the a/y complex possible by
serving as nucleation sites. The chaperone activity of a-crystallin was not affected by the
two sterols, which suggest that the sterols do not bind to the chaperone binding site. This
was confirmed by the bis-ANS results. FTIR and far-UV CD revealed that the secondary
and tertiary structures of a-crystallin were not affected in the presence of the two sterols
regardless of concentration. Furthermore, those two sterols had no significant effect on
the Cu2+ binding capacity of a-crystallin. The hydrophobic sites were not the interaction
sites for those two sterols and the a-crystallin. Thus, no evidence was found that those
two sterols interacted with the a-crystallin specifically.

2.2. FUTURE WORK
In this dissertation, several questions were answered but more issues arose as the
consequence of this work. The role of glycosylation in protein precipitation by PEG was
clarified in the work, but the result was restricted to mAbs. More glycosylated proteins
and their non-glycosylated counterparts need to be considered. Then the effect of
glycosylation can be added to PEG precipitation models quantitatively. Moreover,
pegylation is a popular protein modification that uses PEG instead of glycans to
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covalently attach to protein molecules. Then the role of pegylation in the PEG
precipitation may be investigated.
In paper II, we collected lanosterol solubility data. As shown in the sterols
restoration of cataract patterns, there are more sterols with restoration capabilities. The
solubility data of a few sterols in that pattern are still unavailable. The missing solubility
data is an obstacle to further study of those sterols. The future work should generate more
solubility data of sterols.
Publications reported the failure of lanosterol to restore lenses’ transparencies
during the course of this dissertation. During the same time, more compounds were
discovered to dissolve crystallin aggregates.[43, 44] The mechanism behind this
phenomenon was still unclear. The methods used for this dissertation yielded information
about the sterols’ effects on the crystallin aggregation. Those methods could be extended
to other compounds besides lanosterol and 25-hydroxycholesterol.
Senile cataract was used as a target in sterols restoration experiments. Over the
lifetime of an individual, crystallins are subjected to a wide range of post-translational
modifications that reduced their stabilities and promoted aggregations. [29] Truncation,
deamidation, racemisation, oxidation, and methylation are common post-translational
modifications that appear in cataract-affected eye lenses. In this dissertation, it showed
that the two sterols did not interact with a-crystallin specifically. To better understand the
interaction between sterols and senile cataract lenses, the aggregation processes of
degraded crystallins should be tested with lanosterol and 25-hydroxycholesterol
individually.
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Even though the mechanism of crystallin aggregation dissolved by sterols was
unclear, it is a reasonable assumption that sterols may dissolve other protein aggregates.
Cataract development is not the only disease caused by the protein aggregation.
Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral
sclerosis, and prion diseases are all associated to protein aggregates.[45] The exploratory
study done by Zhou et al. [46] showed that lanosterol disrupted the aggregation of
amyloid-P Peptides, which is associated with Alzheimer's disease. The effects of the
sterols were not limited to lanosterol and 25-hydroxycholesterol on those disease-related
protein aggregates, and those need to be investigated.
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